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It is an important and popular fact that things are not always what they seem. 
For instance, on the planet Earth, man had always assumed that he was more 
intelligent than dolphins because he had achieved so much - the wheel, New 
York, wars and so on - while all the dolphins had ever done was muck about in 
the water having a good time. But conversely, the dolphins had always believed 
that they were far more intelligent than man - for precisely the same reason.
Duglas Adams, The Hitchhiker’s Guide to the Galaxy
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Summary
Lectin-like NK cell receptors are expressed on NK cells and a fraction of T lymphocytes and 
are involved in providing protection against invading pathogens and cancer. Among these, the 
heterodimeric NKG2/CD94 receptors, comprising activating and inhibitory family members, 
recognize the “self” marker HLA-E and have been implicated as receptors of major importance.
The goal of the first part of this work was to investigate the distribution of the CD94/NKG2A 
and CD94/NKG2C receptors within peripheral blood lymphocytes (PBL) to define subpopula-
tions of NK and T lymphocytes expressing these receptors. Flow cytometry analysis displayed 
subpopulations of variable sizes between different individuals. Usually expression of the inhib-
itory CD94/NKG2A defined the largest NK subpopulation, whereas NK cells with the activat-
ing CD94/NKG2C constituted a smaller subpopulation. Cells with expression of both receptors 
were also found at very low percentage. The receptors were further detected on T lymphocytes 
with similar distribution of NKG2A and NKG2C subpopulations. In the next part, we asked 
the question wether the NKG2 isoforms would provide different functions to the subpopula-
tions. The expansion of these subpopulations in co-cultures of peripheral blood mononuclear 
cells (PBMC) with an HLA class Ia-negative, but HLA-E transfected cell line,  was investi-
gated as well as the degranulation upon target cell encounter as measured by CD107a surface 
expression. In co-culture with the HLA-E cells, the NKG2C+ subset displayed preferential ex-
pansion as compared to NKG2A+ cells. Major functional differences of NKG2A and NKG2C 
subpopulations were in freshly isolated cells an inhibition of degranulation of the NKG2A cells 
by HLA-E, whereas after co-culture the NKG2C cells acquired increased killing capacity for 
the HLA-E cells suggesting that the self-ligand HLA-E can function as triggering ligand after 
preactivation of the cells. Finally, the tools to investigate cellular expansion in the context of cy-
tomegalovirus (CMV) infections of fibroblasts and endothelial cells were prepared and initially 
tested as NKG2 receptors have been implicated in CMV immunosurveillance. Corresponding 
amplifications of NK and T cell subpopulations with NKG2 receptors were observed, however 
were to a large degree dependent on the individual donors.
In summary, this work has defined subpopulations of NK as well as T cells by expression of 
NKG2 receptors for which differences in function could be shown in the context of cells with 
expression of the cognate ligand HLA-E and CMV infection. 
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Zusammenfassung
Lektin-ähnliche Natürliche Killer (NK) -Zell Rezeptoren werden von NK und einem Teil der 
T Zellen exprimiert und vermitteln Schutz vor Pathogenen und Tumoren. Dazu gehört die Fa-
milie der heterodimeren CD94/NKG2 Rezeptoren. Diese besitzen entweder inhibierende oder 
aktivierende Funktion, erkennen das “selbst-Antigen” HLA-E und spielen eine wichtige Rolle 
bei der Regulierung der Zellaktivität. 
Ein erstes Ziel dieser Arbeit war es, die Verteilung von CD94/NKG2A und CD94/NKG2C Re-
zeptoren innerhalb der Lymphozyten des periphären Blutes (PBL) zu untersuchen und dadurch 
Subpopulationen von NK- und T- Zellen zu identifizieren. Die durchflusszytometrische Analy-
se ergab Subpopulationen von variierender Größe in Abhängigkeit vom individuellen Spender. 
Die größte Subpopulation wurde über den inhibierenden Rezeptor CD94/NKG2A definiert, 
wohingegen CD94/NKG2C stets von einer kleineren Population exprimiert wurde. Ein sehr 
geringer Prozentsatz an Zellen koexprimierte beide Rezeptoren. Dies gilt sowohl für NK- als 
auch T- Zellen. 
Des Weiteren haben wir untersucht, inwieweit die Expression von NKG2 Isoformen eine Aus-
wirkung auf die Funktionen der Subpopulationen hat. Dafür wurde die Expansion dieser Sub-
populationen in Kokulturen von mononukleären Zellen des periphären Blutes (PBMC) mit 
einer HLA Klasse Ia negativen, aber HLA-E transfektierten Zelllinie analysiert. Weiters wur-
de die  Degranulierungs- Aktivität über CD107a gemessen. In der Kokultur zeigten NKG2C+ 
Zellen verstärkte Expansion im Vergleich zu NKG2A+ Zellen. Die wichtigsten funktionellen 
Unterschiede zwischen NKG2A und NKG2C positiven Subpopulationen waren eine Inhibition 
der Degranulation von frisch isolierten NKG2A+ Zellen in Abhängigkeit von HLA-E und ein 
HLA-E-vermittelte Aktivierung von zuvor kokultivierten, NKG2C+ Zellen. Dies deutet darauf 
hin, dass der “selbst-Ligand” HLA-E voraktivierte Zellen über NKG2C induzieren kann. 
Schließlich wurden Methoden etabliert, um Zellexpansion im Zusammenhang mit Zytomega-
lovirus-infizierten Fibroblasten und Endothelzellen zu untersuchen, da NKG2 Rezeptoren für 
die Kontrolle von CMV durch das Immunsystem eine wichtige Rolle spielen dürften. Eine vom 
Spender abhängige, CMV assoziierte Amplifizierung von NKG2 exprimierenden NK und T-
Zell Subpopulationen wurden festgestellt. 
Zusammenfassend konnten durch die in dieser Arbeit durchgeführten Experimente Subpopu-
lationen auf NK- und T- Zellen anhand der Expression von NKG2 Rezeptoren definiert und 
funktionale Unterschiede im Zusammenhang mit HLA-E und CMV festgestellt werden. 
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1.	Introduction
1.1	Reflecting	“self”:	The	major	histocompatibility	complex	(MHC)	class	I	
Major histocompatibility complex class I proteins are expressed, with few exceptions, by all 
healthy nucleated cells. The expression level varies between different cell types. For example, 
trophoblast and germinal cells express no MHC class I molecules and cells of the nervous 
system express little or none whereas lymphoid tissues express high levels of MHC class I. In 
humans, the corresponding proteins are termed human leukocyte antigens (HLA). Their func-
tions are diverse ranging from antigen presentation and indication of “self” and “non-self” to 
protecting the foetus from rejection (Agrowal & Kishore, 2000).
MHC class I heavy chains assemble in the endoplasmatic reticulum (ER) to a heterodimer 
with b
2
-microglobulin (β
2
m). Endogenous proteins that are degraded by the proteosome and 
transported to the ER via TAP (transporter associated with antigen processing) are processed 
and loaded onto the heterodimers by the peptide loading complex. Exogenous proteins that are 
partially processed in endosomes and reach the cytosol can also be loaded onto MHC class I 
molecules. MHC-I/β
2
m/peptide complexes enter the golgi network and finally reach the cell 
surface where they are recognized by T and NK cells (Rodgers & Cook, 2005). An important 
mechanism to recognize intracellular pathogens such as viruses is the presentation of pathogen-
derived peptides in the context of MHC class I to cells of the immune system, in particular 
cytotoxic T cells (Hansen & Bouvier, 2009).
The classical MHC class I alleles (MHC class Ia) coding for HLA-A, -B and -C are highly 
polymorphic in the regions for the peptide-binding sites. Two or three “anchor residues” are 
responsible for specific peptide binding, which enables loading of diverse eight to ten amino 
acids long peptides. 
In contrast, few alleles exist for the non-classical MHC class I (MHC class Ib) genes HLA-E, 
-F, and -G. HLA-G and -F diverged from MHC class Ia 5–20 million years ago. HLA-G was 
shown to present peptides in a similar way as MHC class Ia molecules do, and the same is prob-
ably true for HLA-F. Their expression is limited to some tissues and cell types where the func-
tions are not yet fully clarified but contribution to immunoregulation, allergy, autoimmunity 
and embryonic development was implicated (Rodgers & Cook, 2005). 
HLA-E arose more than 65 million years ago from MHC class Ia and is expressed in most 
tissues including the placenta. Rodents have several MHC molecules of this type, fulfilling 
various functions, whereas in humans HLA-E represents the only member (Rodgers & Cook, 
2005). HLA-E is the least polymorphic of all MHC class I molecules with probably only 3 dif-
ferent alleles existing, two of which (HLA-E*0101 or HLA-ER and *0103 or -EG) are nonsyn-
onymous resulting in a single amino acid (arginine (R) or glycine (G)) difference not located 
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within the peptide binding groove (Grimsley, et al., 2002; Strong, et al., 2003). When HLA 
proteins are co-translationally translocated to the ER, the signal peptide is cut off and either the 
N-terminal part or the total signal peptide is released to the cytoplasm where the proteosome 
further digests it and, after re-import into the ER, these peptides are loaded onto HLA-E (Bai, et 
al., 2000; Rodgers & Cook, 2005). Five anchor residues in HLA-E cause tight restriction on the 
variety of bound peptides. Classical MHC class I and HLA-G derived molecules can be loaded 
onto HLA-E leading to its surface expression (Sullivan, et al., 2008). Thus, examining HLA-E 
surface content represents an additional control mechanism how cells can monitor MHC class I 
expression. CD94/NKG2 NK receptors and occasionally the T cell receptor of ab CD8+ T cells 
can bind HLA-E supporting a primary importance for NK receptors but also a role for acquired 
immunity (Sullivan, et al., 2008). 
Figure	1.1:	HLA-E	surface	mobilization	and	receptor	engagement
Signal peptidase (SPase) and signal peptide peptidase (SPPase) mediate the release of the 
MHC class I leader peptide to the cytoplasm, where it is processed by the proteasome leading 
to short oligomeres that are re-imported to the ER in a TAP (transporter associated with anti-
gen processing) dependent manner. b2-microglobulin (b2m) associated, peptide-loaded HLA-
E molecules pass through the golgi network and are transported to the cell surface where they 
are recognized by CD94/NKG2 receptors on NK or T cells. 
(Figure adapted and reprinted by permission from Macmillan Publishers Ltd: [Nature Re-
views Immunology] (Rodgers & Cook, 2005), copyright (2005)) 
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1.2	Natural	Killer	(NK)	Cells
1.2.1	The	classification	of	NK	cells	within	the	immune	system
According to the time frame, specificity of an immune reaction and evolutionary history, the 
vertebrate immune system consists of two functionally distinct branches:
The innate immune system includes physical and chemical barriers (skin, antimicrobial chemi-
cals), blood proteins (the complement system) and the cellular components neutrophils, macro-
phages, NK cells and dendritic cells. The limited diversity of their germline-encoded receptors 
restrict cells of the innate immunity to the recognition of structures shared by groups of related 
microbes but allows a defence reaction within hours. Dendritic cells process and present anti-
gens to cells of the adaptive immune system, serving as a link (Abbas, et al., 2007). 
The evolutionary younger adaptive immune system with the cardinal features specificity, di-
versity, memory, tolerance and self-limitation mediates its effector functions via B lympho-
cytes secreting antibodies (humoral response), helper T lymphocytes activating macrophages 
or B cells, and cytotoxic T-lymphocytes (cellular response). Several days are needed to select 
and amplify antigen-specific cells or antibodies recognizing an unknown pathogen. Upon re-
encounter, memory allows a highly specific, rapid response (Abbas, et al., 2007).
In 1975 it was discovered by Kiessling et. al, that a subset of mouse peripheral blood lympho-
cytes (PBL) kill certain tumor target cells without prior sensitization. Germline encoded cell 
surface receptors that do not require somatic recombination and the property of “spontane-
ous killing” led to the term “natural” killer cells and their classification to the innate immune 
system. Unlike the phagocytic cells of the innate immunity (neutrophils, macrophages) which 
rely solely on conserved pattern-recognition receptors, it turned out that NK cells are focused 
on recognition of major histocompatibility complex (MHC) molecules and belong to the lym-
phocytes where they make up about 15% in humans (Lanier, 2005; Wilk, et al., 2008). Ten 
years after their first definition the “missing self” hypothesis was proposed: Polymorphic MHC 
class I molecules, which are abundantly expressed on healthy cells and present self-peptides to 
T lymphocytes are recognized also by NK cells to distinguish between “self” and “non-self” 
(Ljunggren & Klärre, 1985). Tumor or virus transformed cells frequently downregulate MHC 
class I expression making them targets for killing. 
Together with B and T cells, NK cells share a common lymphocytic progenitor and, according 
to their current definition, are not found in species lower than fish.  Nowadays, NK cells ap-
pear to be a transitional cell type connecting innate and adaptive immune systems and having 
coevolved with T cells rather than being an ancient immune effector cell type (Lanier, 2005; 
Joncker & Raulet, 2008).
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1.2.2	NK	cell	education	and	activation
NK cells use highly cytotoxic preformed lytic granules for target cell lysis. To avoid possible 
unspecific killing, a balance of inhibitory and activating signals controls the granule release. 
If a normal cell gets encountered, inhibitory signals, coming mainly from inhibitory receptors 
recognizing MHC class I molecules, dominate and no activation takes place. If either stimula-
tory ligands for activating receptors are upregulated (induced-self recognition) or inhibitory 
molecules are downregulated (missing-self recognition), killer-cell activation leads to cytokine 
and granule release resulting in elimination of the target cell (Raulet & Vence, 2006).
To achieve self-tolerance and optimal reactivity it was proposed that NK cells have to express 
at least one inhibitory receptor, recognizing self-MHC class I, to get fully functional. Such cells 
are called “licensed” or “higher-functioning” as opposed to “unlicensed” or “hyporesponsive” 
(Raulet & Vence, 2006). Early models for the process of licensing focussed on the receptor 
acquisition during development: The “sequential-cumulative model” proposes that during a 
certain time frame of NK cell development, receptors are expressed stochastic but stable. Ac-
cumulation of new receptors continues until an inhibitory receptor engaged self-MHC class I 
with sufficient strength (Hanke, et al., 2001). Alternatively, stochastic receptor expression of a 
preformed initial receptor repertoire takes place and a selection process favours NK cells with 
“at least one” self-MHC specific inhibitory receptor. Both mechanisms were later found to be 
Figure	1.2:	MHC	class	I	dependent	mechanisms	of	NK	cell	activation
If an NK cell encounters a normal cell, the balance between activating and inhibitory signals 
(mainly from MHC class I specific inhibitory receptors) provides the basis for non-reactivity 
to “self”. Downregulation of MHC class I (missing-self) or upregulation of stimulatory li-
gands (induced-self) due to transformation or infection leads to NK cell activation and target 
cell killing. (Raulet & Vance, 2006)
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incapable to ensure that “at least one” inhibitory receptor for “self” is expressed on each NK 
cell (Joncker & Raulet, 2008).  The process, that NK cells are proposed to have to undergo for 
establishing responsiveness, was named NK cell “licensing”, “education” or “arming” and the 
corresponding models “arming model” or “licensing model” according to which  the interac-
tion of inhibitory receptors with MHC-class I receptor expressing cells induces responsiveness 
(Kim, et al., 2005; Yawata, et al., 2008). The arming/licensing models require that NK cells 
(and accordingly their activating receptors) are by default in an “inactive”, “unresponsive” 
state, for which there is no proof yet (Raluet & Vence, 2006; Held, 2008). If this is not the case, 
the primary attribute for a “selection” remains that NK cells have to ensure the property of tol-
erance for “self” (Held, 2008). An alternative viewpoint for example is taken to account in the 
“disarming” model where NK cells are highly functional by default and if excessive activating 
signaling occurs due to lack of inhibitory receptor signaling, cells do not get fully responsive 
and potentially acquire functional anergy (Joncker & Raulet, 2008). 
Models relying solely on MHC class I inhibitory receptor expression fail to explain some as-
pects of NK-cell biology: Humans and mice that lack proper MHC class I expression due to 
mutations effecting TAP or b2m as well as mice carrying both defects resulting in undetectable 
MHC class I surface expression, harbour usual numbers of NK cells with a widely normal re-
ceptor repertoire and are found self-tolerant. Additionally, a substantial subset of self-tolerant 
cells without MHC class I inhibitory (KIR- NKG2A-) receptors exist in healthy humans and 
mice (Kumar & McNerney, 2005; Anfossi, et al., 2006; Joncker & Raulet, 2008). Whereas the 
role of MHC class I dependent “self” recognition for NK cells to become fully functional is 
beyond question, there is further considerable evidence that MHC class I independent mecha-
nisms are also involved. 
Recent findings indicate that “education” is quantitative and probably also reversible. In the 
“rheostat’’ model (Fig. 1.3), the quantity of inhibitory and stimulatory interactions to which 
cells are exposed during development provides the basis for non-reactivity to self. An equal 
amount of activating and inhibitory interactions results in high responsiveness, whereas an ac-
cess of activating signals would lead to a reduction of responsiveness. In terms of cell activation 
it is still the balance of activating and inhibitory signals governing the outcome but according 
to this theory, the set-point can be changed if persistent conditions change, leading to tolerance 
of pathogens or cancer because newly arising NK cells are “used” to the altered steady-state 
situation (Joncker & Raulet, 2008; Brodin & Höglund, 2008).
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Upon encounter of a target cell through adhesion molecules like LFA-1 (a b
2
-integrin) binding to 
ICAM-1, the decision between activation and inhibition takes place in the immunological syn-
apse. In order to avoid cell activation, signal transduction of inhibitory signals and inhibition of 
activating responses is necessary. It is currently thought that this is enabled by close proximity 
of the receptors and association with Src kinases which phosphorylate immune tyrosine-based 
inhibitory motifs (ITIMs). Upon phosphorylation, enzymes like SHP-1 tyrosine phosphatase 
are recruited which dephosphorylate immune tyrosine-based activating motifs (ITAMs) present 
on the adaptor proteins of many activating receptors. Furthermore, inhibition includes preven-
tion of the actin-dependent recruitment of activating receptors to lipid rafts by SHP-1 which 
inactivates Vav1 dependent Rac1 activation and thereby prevents actin polymerization (Fig. 
1.4). Polarization and the localized cell inhibition renders NK cells susceptible for activation 
taking place in different membrane areas. Induction of cytotoxicity and cytokine production in 
resting NK cells often requires synergy of several receptors. Much more activating than inhibi-
tory receptors are expressed on NK cells and if activation signals exceed the inhibitory, effector 
functions are mediated (Watzl & Long, 2003; Barber, et al., 2004; Bryceson, et al., 2006; Long, 
2008; Biassiani, 2009; Cheent & Khakoo, 2009).
Figure	1.3:	The	“reostat”	model	of	NK	cell	responsiveness
The amount of inhibitory and activating signals received during NK cell development gov-
erns the responsiveness. An equal amount of inhibitory and activating signals (a) results in 
“high responsiveness” whereas both weak or missing inhibitory “self” signals (b, c) and an 
excess of activating signals (d) leads to reduced reactivity (Joncker & Raulet, 2008).
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Another important aspect for NK cell activation, function, proliferation and survival is the in-
fluence of cytokines. Cytokines like IL-2, IL-12, IL-15 and IL-18 as well as type I interferons 
(IFN-a, -b) released from various cell types have a major impact on natural killer cells and are 
part of the cross-talk with other cells during an immune reaction. Especially dendritic cells were 
shown to provide additional signals required for fully activated natural killer cells (See chapter 
1.1.4). (Strowig, et. al., 2008)
1.2.3	Receptors,	adaptor	proteins	and	ligands	of	human	NK	cells
Germline restriction necessitates NK cells to express a multitude of activating and inhibitory 
receptors to enable stringently controlled diverse functions. The specificity of their extracel-
lular parts differs to a large extent but all inhibitory receptors share the conserved cytoplasmic 
sequence of an ITIM and adaptor proteins like Dap12 which contain ITAMs or other signaling 
motifs are used to transduce activating signals (Biassiani, 2009). This chapter does not exhaust 
but focuses on the receptors of capital importance for NK cells. 
1.2.3.1 MHC class I specific receptors
The killer-cell immunoglobulin (Ig)-like receptor (KIR, formerly termed killer cell inhibitory 
receptor (www.ebi.ac.uk/ipd/kir, june 2009) family contains inhibitory as well as activating 
transmembrane receptors which are encoded by at least 15 different genes and recognize the 
polymorphic α1-α2 area of HLA allotypes. Recombination and gene shuffling led to a rapid 
Figure	1.4:	Regulation	of	inhibitory	and	activating	NK	cell	signaling		
Adhesion molecules like LFA-1 are important for the binding to a potential target cell and 
to induce actin polymerization required for the recruitment of activating receptors to lipid 
rafts and therefore major players during cell activation. If inhibitory NK cell receptors (like 
inhibitory KIR and CD94/NKG2A) encounter a cognate ligand, SHP-1 is recruited which de-
phosphorylates Vav1 and thereby prevents the induction of an activating signal (Long, 2008).
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evolution and large variability of gene content and allelic polymorphism between species and 
individuals (Gendzekhadze, et al., 2006; Biassoni, 2009). Acquisition of KIR expression by NK 
cells is random and sequential resulting in stochastic expression independent of self MHC class 
I leading to cells co-expressing multiple KIR (Andersson, et. al, 2009; Cooley & Miller, 2009). 
Inhibitory KIR use ITIMs on their intracellular part to transduce signals. Activating KIR dimer-
ize with Dap12 or FcεRIγ which contain ITAMs (Biassiani, 2009). KIR can also be expressed 
by T cells where they act as co-receptors and influence lymphokine production (D’Andrea, et 
al., 1996).
Inhibitory and activating members of the C-type lectin-like family of receptors recognize the 
non-classical MHC class I molecule HLA-E. In chapter 1.3 these receptors will be described in 
more detail.
Leukocyte Ig-like receptors (LILR) also known as Ig-like transcripts (ILTs) recognize the high-
ly conserved α3 domain of MHC class I complexed with b
2
-microglobulin resulting in broad 
specificity. The 14 inhibitory or activating LILR known are predominantly expressed on myelo-
monocytic cells. For NK cells LILRB1 coding for CD85j (LIR1/ILT2) is of special interest. It 
recognizes several classical and nonclassical MHC class I molecules as well as the cytomega-
lovirus encoded MHC class I homologue UL18 leading to inhibitory signals. CD85j was shown 
to interfere with NK adhesion to target cells and to inhibit CD16 dependent lysis. On the other 
hand, CD85j+ NK cells potentially control HIV-1 replication in dendritic cells (Brown, et al., 
2004; Cosman, et al., 1997; Scott-Algara, et al., 2008).
1.2.3.2 Receptors not specific for MHC class I
In contrast to MHC class I specific receptors, the majority of the receptors not recognizing 
MHC class I are present on the surface of most NK cells. The natural cytotoxicity receptors 
NKp30 (NCR3), NKp44 (NCR1), NKp46 (NCR2) which are members of the Ig-like superfam-
ily and the lectin-like receptor NKG2D (KLRK1) are the main receptors for NK-mediated kill-
ing (Biassiani, 2009; Cheent & Khakoo, 2009).
NKp30 and NKp46 are expressed by the majority of resting and activated NK cells, whereas 
NKp44 is expressed upon activation (Biassiani, 2009). Not much is yet understood about the 
ligands of NCR but it seems that functional cooperation takes place as the engagement of any 
NCR results in activation of a common set of tyrosine kinases and the induction of down-
stream signaling of other NCR (Augugliaro, et al., 2003; Bottino, et al., 2005). NKp46 and 
NKp44 were shown to recognize hemagglutinin on virus infected cells (Mandelboim, et al., 
2001; Arnon, et al., 2001). NKp46 is further involved in killing of Mycobacterium tuberculosis 
infected monocytes via vimentin binding (Garg, et al., 2006) and NKp44 has been suggested to 
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bind directly to several bacteria (Esin, et al., 2008). In addition, inhibition of NCR by specific 
antibodies revealed their major role in NK cell mediated lysis of tumors (Bottino, et al., 2005) 
and it is debated if membrane-associated heparan sulfate proteoglycans (HSPG) could serve as 
cellular ligands at least for NKp44 and NKp46 (Biassiani, 2009). HLA-B associated transcript 
3 (BAT3) and B7 protein family member B7-H6 were identified as tumor antigens for NKp30 
(Pogge von Strandmann, et al., 2005; Brandt, et al., 2009).    
Like other natural killer group 2 (NKG2) proteins, NKG2D is a member of the C-type lectin-
like molecules. The type II transmembrane anchored protein is expressed as a disulfide-linked 
homodimer and not as a heterodimer with CD94 like other NKG2 family members. NKG2D 
recognizges stress induced “self-proteins” expressed upon DNA damage, infection or as a result 
of toll-like receptor (TLR) signalling and is therefore important for tumor immunosurveillance 
and pathogen defence. The identification of at least 7 different ligands gives NKG2D an ex-
ceptional position among NK cell activating receptors: MHC class I related chain A (MICA), 
MICB, cytomegalovirus UL16-binding protein 1 (ULBP1), ULBP2, ULBP3, ULBP4 and reti-
noic acid early transcript 1G (RAET1G) and RAET1E are recognized. All of these ligands 
share the common feature of MHC-class-I-related α1α2 domains but aside of that are highly 
variable in amino-acid sequence and domain structure. Upon ligand binding, a tyrosine motif 
on the associated adaptor protein Dap10 (which lacks ITAM) is phosphorylated and phospha-
tidylinositol-3 kinase as well as Grb2 and the effector molecule Vav1 has to interact in order 
to induce activation (Upshaw, et al., 2006; Eagle & Trowsdale, 2007; Bryceson & Ljunggren, 
2008; Jonjic´, et al., 2008).
CD16 (FcγRIII), also termed low-affinity Fcγ receptor, is expressed by most NK cells and 
recognizes the Fc part of IgG. Association with the ITAM bearing CD3z or Fce receptor I (Fc-
eRI) γ chains is required for signal transduction. Antibody-coated target cells are recognized, 
inducing antibody-dependent cellular cytotoxicity (ADCC). CD16 engagement appears to be 
the only example for an activating NK cell receptor sufficient to induce degranulation in rest-
ing cells without co-activation of other activating receptors (Bryceson, et al., 2006). Aside of 
its important role in ADCC, Mandelboim et al. showed evidence for an antibody-independent 
function for lysis of some virus infected and tumor cells by recognition of a ligand other than 
Fcγ (Mandelboim, et al., 1999; Moretta, et al., 2008).
Signaling lymphocytic activation molecules (SLAM) 2B4 (CD244) NTB-A (SLAMF6, Ly108) 
and CS1 (SLAMF7, CRACC) belong to CD2 superfamily and are thought to act as co-recep-
tors during activation of natural cytotoxicity. The proteins have in common that they show 
homophilic interactions or recognition of proteins encoded within the CD2 gene family. All 
of them contain an extracellular N-terminal nondisulfide bonded V type Ig-like domain and 
a membrane-proximal C2 domain. SLAMs play an important role in innate and adaptive im-
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munity. Immunoreceptor tyrosine-based switch motifs (ITSM) on their cytoplasmic tail can, 
similar to ITIM, recruit Src homology 2 (SH2) domain-containing proteins. Receptor type and 
cellular context influences wether an ITSM transduces an activating or an inhibiting signal. In 
healthy individuals, SLAMs are activating NK cell receptors (Ostrakhovitch & Li, 2006; Bias-
soni, 2008).  
NKR-P1A (CD161) is a C-type lectin receptor expressed on a subset of NK and 25% of periph-
eral T cells (Lanier, 1994; Lanier, 2005). Lectin-like transcript 1 (LLT1 or CLEC2D) is a ligand 
for NKR-P1A and interaction inhibits NK and CD8+ T cells but fails to inhibit CD4+ T cell acti-
vation. LLT1 is expressed on NK cells, T cells, activated dendritic cells and B-cells suggesting a 
function in the cross-talk of NK and antigen-presenting cells (APC). The exact nature of signals 
by CD161 is still to be clarified (Aldemir, et al., 2005; Rosen, et al., 2008).
The ability to recognize conserved structures on invading microorganisms (pathogen-associat-
ed molecular patterns, PAMPs) makes Toll-like receptors (TLRs) to important players of innate 
immunity. NK cells express TLR 3 and 9 which recognize double-stranded RNA from viruses 
and non-methylated CpG DNA from bacteria, respectively. These interactions could be espe-
cially important during early recruitment to inflammatory sites (Sivori, et al., 2004; Tsan, 2006).
1.2.4	Functions	of	NK	cells	 in	human	peripheral	blood	and	the	assignment	to	NK	sub-
populations	
The exertion of spontaneous cytotoxicity originally characterized natural killer cells but recent 
studies have clearly shown that regulation of immune responses via production of cytokines is 
an equally important contribution of NK cells to an immune reaction (Strowig, et al., 2008). 
The highly organized multifactor process cytotoxicity can be mediated by three different path-
ways that results in the induction of apoptosis in the target cell. (Chavez-Galan, et al., 2009) 
Membrane blebbing, chromatin margination, and the breakdown of chromosomal DNA charac-
terize apoptotic cells and finally end up in cell death (Schwartz, et al., 1992).
Granule-dependent exocytosis is the most important NK cell effector mechanism (Lanier, 
2005). Upon activation, preformed lytic granules are guided by microtubule mobilization to 
the immunological synapse where lytic molecules are released towards the target membrane. 
The exact mechanism how this pathway works is still debated but the importance of perforin, 
which is found soluble within granules and can form cylindrical pores in membranes, is clear. 
Depending on the proposed mechanism, perforin either forms pores in the target membrane, al-
lowing lytic molecules to path through, or it enables the release of these molecules after getting 
endocytosed together in vesicles by the target cell. Granzymes and granulysin can serve as lytic 
molecules that, once inside the cell, induce apoptosis pathways (Chavez-Galan, et al., 2009). 
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Expression of death receptor ligands like TNF-related apoptosis-inducing ligand (TRAIL) and 
Fas ligand (FasL) and their interaction with TRAIL-R1 or -R2 or Fas, respectively, on the target 
cell surface is the second pathway leading to apoptosis. FasL can be expressed as membrane-
anchored trimer or be stored in intracellular microvesicles and expressed on the cell surface 
upon stimulation. Besides, membrane shaping results in soluble FasL which can be either pro- 
or anti-apoptotic, depending on the mode of interaction either as a monomer (anti-apoptotic) or 
as a multimeric structure and if aggregated with extracellular matrix proteins (pro-apoptotic). 
At last, death receptor signaling leads, depending on the cell type, to active caspase-8 or release 
of pro-apoptotic factors from the mitochondria ending up in cell death (Chavez-Galan, et al., 
2009).
Last, the cytokine tumor necrosis factor can, aside of other functions, induce apoptosis via 
crosslinking of TNF with TNF receptor type 1, which carries cytoplasmic death domains 
(Chavez-Galan, et al., 2009).
Cytokines released by NK cells participate in immunomodulation of innate and adaptive im-
munity and fulfill direct antiviral functions (Strowig, et al., 2008). Production of tumor necrosis 
factor (TNF) and the type I interferons IFN-α/β and IFN-g suppresses viral replication, en-
hances NK cell mediated cytotoxicity and exerts regulatory functions on the immune reaction 
(Biron & Brossay, 2001). The effects of IFN-g are manifold: It upregulates cell-surface MHC 
class I, increasing the potential to recognize foreign pathogens and induced changes in the com-
position of the proteasome are thought to positively influence quantity, quality, and repertoire 
of peptides for class I MHC loading. Decreasing the local blood flow rate and upregulation of 
chemokine and adhesion-molecule expression by IFN-g recruits cells of the immune system. 
Moreover, microbicidal effector functions of macrophages are activated and isotype-switching 
of B-cells is promoted (Schroder et al., 2004). 
The cross-talk of NK cells with dendritic cells (DC) is of particular importance. On the one 
hand, NK cells are activated and induced to proliferate by mature DC via IL-2, IL-12, IL-15, 
IL-18 and INF-a/b, on the other hand, maturation of DC is triggered by NK cells via TNF and 
IFN-g. Interestingly, immature DC are susceptible to NK mediated killing because of low-level 
MHC class I expression, and maturation is accompanied by MHC class I upregulation which 
acts protective (Degli-Esposti & Smyth, 2005). Mature DC efficiently prime Th1 cells and 
the interplay with NK cells was shown to be able to induce CD8+ T cell-mediated anti-tumor 
responses in the absence of CD4+ T cell help. Secondary lymphoid organs are another site of 
NK-DC interaction. Upon inflammation, NK cells are recruited to the T cell zone in lymph 
nodes where close proximity with DC can activate NK cells to produce INF-g which mediates 
Th1 polarization required to prime an immune response (Gregoire, et al., 2007; Strowig, et al., 
2008). Another level of complexity was added by the finding that NK cells can also induce 
differentiation of monocytes into DC via direct contact, GM-CSF and CD40 ligand (CD154) 
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release (Zhang, et al., 2007). 
To tightly regulate an immune reaction, other cells can also impair NK cell functions for ex-
ample by secretion of IL-10 produced by T cells, macrophages and DC (Couper, et al., 2008) 
and TGF-b released by regulatory T cells or tumors cells (Wahl, et al., 2006).  
The quantity of neural cell adhesion molecule (NCAM, CD56, Leu-19, NKH-1) expression 
on natural killer cells distinguishes two functionally distinct subsets with the major functions 
“cytokine production” or “cytotoxicity”. (Lanier, et al., 1986) CD56 is expressed by virtually 
all NK cells, even so, its function has yet to be defined. Cells expressing high levels of CD56 
on their cell surface are referred to as CD56bright and those expressing 5 to 10 fold less as CD-
56dim NK cells. Both subsets express the activating receptors NKp30, NKp46 and NKG2D but 
their gene expression profiles vary to a large extent with more than 470 differentially expressed 
transcripts, almost 2/3 of which are exclusively found in one subset (Wilk, et al., 2008) .
Figure	1.5:	Surface	protein	expression	&	functions	of	NK	cell	subpopulations	
CD56bright NK cells express high levels of inhibitory CD94/NKG2A, low levels of CD16, 
are potent cytokine producers but show weak cytotoxic activity. Conversely, CD56dim NK 
cells express high levels of CD16 (making them to potent mediators of ADCC), few CD94/
NKG2A, produce low levels of cytokines but are highly cytotoxic. Both subsets are equally 
capable of lymphokine activated killing (LAK). (see text for further details) 
KIR, killer Ig-like receptors; NKR, NK receptor; ADCC, antibody-dependent cellular cyto-
toxicity (Cooper, et al., 2001).
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The “classical”, cytotoxic natural killer cells make up 90% in peripheral blood and are of the 
CD56dim phenotype (Wilk. et al., 2008). KIR, high surface levels of CD16 as well as intracel-
lular perforin content and expression of certain chemokine receptors make CD56dim NK cells to 
potent effector cells. CXCR1 (CXC chemokine receptor 1) and CX
3
CR1 are “site of inflamma-
tion markers” and binding of the respective ligands IL-8 (CXCL8) and fractalkine (CX
3
CL1) 
was shown to induce migration of CD56dim NK cells (Campbell, et al., 2001; Berahovich, et al., 
2006; Moretta, et al., 2008). Various cell types like macrophages, neutrophils and endothelial 
cells release these cytokines during inflammation leading to NK cell recruitment. Furthermore, 
precursors of dendritic cells (DC) accumulate in inflamed tissues where they become immature 
dendritic cells (iDC) that secrete CXCL8 and CX
3
CL1 upon antigen capture. The resulting 
cross-talk between iDC and NK cells is likely to induce iDC development to mature antigen 
presenting cells which may in turn produce cytokines that recruit further NK cells. Finally the 
mature DC are induced to migrate to secondary lymphoid organs. (Moretta, 2002) The che-
motactic agonist Chemerin, the ligand for ChemR23 which is expressed on CD56dim but not 
CD56bright cells, is another chemokine important for the attraction to inflamed sites. (Moretta, et 
al., 2008) Despite these recruitment mechanisms, in several inflammatory sites the majority of 
NK cells was found to be CD56bright (Strowig, Brilot & Münz, 2008). This subset makes up only 
10% of peripheral blood NK, does not express most KIR isotypes and either no or low density 
of CD16 but high levels of NKG2A and the secondary lymphoid organ (SLO) homing markers 
chemokine (C-C motif) receptor 7 (CCR7), CD62L (L-selectin) and CXCR3. Upon stimula-
tion with proinflammatory molecules, 56bright NK are potent producers of cytokines like IFN-g, 
TNF, GM-CSF, IL-10 and IL-13, depending on the stimuli. Resting CD56bright CD16- cells lack 
perforin expression and require prolonged activation to become cytotoxic (Carson, et al., 1997; 
Ferlazzo, et al., 2004; Strowig, et al., 2008, Poli, et al., 2009). The overrepresentation of CD-
56bright cells at sites of inflammation may be due to the ability to bind macrophage inflammatory 
protein (MIP) -1a , MIP-1b, and RANTES (CCL5) via CCR5. Another possibility is that CD-
56dim cells differentiate into C56bright cells upon stimulation with certain cytokines (Takahashi, et 
al., 2006; Loza & Perussia, 2004) although several studies suggest a differentiation of CD56bright 
into CD56dim upon prolonged activation. (Dalbeth, et al., 2004; Strowig, et al., 2008) In addi-
tion, DC mediated stimulation is likely to preferentially induce CD56bright expansion (Vitale, et 
al., 2004). The reciprocal expression of the receptor-ligand pair CD62L and PEN5-PSGL-1 by 
CD56bright and CD56dim NK cells, respectively, suggests a potential interaction of the two sub-
populations (Farag & Caligiuri, 2006). In consistence with the homing marker expression, 75% 
of NK cells in lymph nodes are CD56bright. Because lymph nodes harbor 40% of total lympho-
cytes, 5% of which are NK cells and peripheral blood contains only 2% of the total lymphocytes 
(10% NK), CD56bright natural killer cells may outnumber CD56dim in the human body (Ferlazzo, 
et al., 2004). The existence of so many potent immunoregulatory CD56bright cells at various sites 
of the immune system further emphasizes that NK cells are more than just effective killers. 
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1.3	The	human	natural	killer	group	2	(NKG2)	receptor	family
1.3.1	Genomic	organization	and	evolution
The NKG2 proteins are encoded by the corresponding KLRC genes located within the NK gene 
cluster on chromosome 12 (Plougastel & Trowsdale, 1998). In humans, the family is represent-
ed by NKG2-A, -B, -C, -D, -E, -F, -H with NKG2A/B and NKG2E/H being splice variants of 
the same gene (Bellon, et al., 1999; Brostjan, et al., 2002). CD94 (KLRD1) and the NKG2 pro-
teins are highly conserved during speciation and probably arose at the time of the first tetrapods 
>400 million years ago (Biassoni, 2009). Though being evolutionary conserved, polymorphism 
screening of NKG2-A and -C revealed ten polymorphisms of non-coding regions and introns 
and one variation in the transmembrane region of NKG2A in the Japanese population as well 
as homozygous deletion of NKG2C in about 4% of healthy Dutch and Japanese individuals 
(implying 20% carrying the deletion haplotype) (Hikami, et al., 2003; Miyashita, et al., 2004). 
The homodimeric NKG2D receptor has only distant functional and structural relationship to 
the other family members and was therefore described separately in chapter 1.2.3.1. The CD94/
NKG2 protein family consists of inhibitory as well as activating receptors. Inhibitory NKG2A 
and activatingNKG2C and E have 56% amino acid homology in the intracellular and trans-
membrane domains and more than 94% homology in their extracellular domains. The extracel-
lular similarity allows binding to the same cognate ligand HLA-E (Borrego, et al., 2006). 
Figure	1.6	Genomic	location	and	organization	of	CD94	and	NKG2	genes	on	chromo-
some	12
All genes coding for NKG2 receptors as well as the gene the invariant CD94 chain (except 
for homodimeric NKG2D) locate in close proximity within the NK cell receptor complex on 
chromosome 12 (Borrego, et al., 2001).
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1.3.2	CD94/NKG2	receptor	structure	and	interaction	with	HLA-E
The CD94 and NKG2 receptor chains are type II transmembrane glycoproteins with an extra-
cellular domain containing a C-type lectin-like domain (CTLD) which is connected via a stalk 
region to the transmembrane and cytoplasmic part (Sawicki, et al., 2001). Historically, C-type 
(or Ca2+ dependent) lectins were defined as proteins containing homologous modular carbo-
hydrate recognition domains that bind carbohydrate moieties in a Ca2+-dependent manner and 
contain invariant disulfide bonds (Boyington, et al., 1999). However, less than 10% of CTLD 
(in Caenorhabditis elegans) were found to contain features for Ca2+ binding sites and sugar 
recognition is also not shared by all members of the superfamily. The structural similarity of all 
CTLD is thought to be a consequence of evolution from a common ancestor protein (Dricka-
mer, 1999; Sawicki, et al., 2001). The CTLD of the CD94/NKG2 receptors are subclassified to 
the “C-type lectin-like domains of NK receptors” (NKDs) which are Ca2+ independent and ap-
pear to be rather protein binding (Sawicki, et al., 2001). Except for the homodimeric NKG2D, 
dimerization of the NKG2 protein with CD94 via disulfide-linkage is necessary to become a 
functional receptor expressed on the cell surface (Carretero, et al., 1997). 
Nanomers, derived from the leader peptide of different MHC-class I proteins bind to HLA-E. 
The amino acid composition of these nanomers and the HLA-E haplotype influence the ther-
mal stability of the peptide/HLA-E complex, its surface expression level and the affinity of the 
CD94/NKG2-peptide/HLA-E interaction (Strong, et al., 2003; Hoare, et al., 2008). Although 
inhibitory as well as activating CD94/NKG2 receptors both recognize HLA-E/peptide com-
plexes, the binding affinity of the inhibitory CD94/NKG2A is always found to be 6-fold high-
er than the interaction of the triggering CD94/NKG2C (Kaiser, et al., 2008), whereas CD94/
NKG2E shows very similar binding properties to CD94/NKG2A. The HLA-E haplotype does 
not have an effect on these affinity differences (Kaiser, et al., 2005).
The major function of the NKG2 chain in the heterodimeric receptor might be to provide the 
signaling capacity. Differences in three amino-acids within the interface of CD94 and NKG2-A 
or -C indirectly account for the ligand affinity-variation possibly due to subtle conformational 
changes in the invariant CD94 protein, that contains the most important interaction sites with 
HLA-E and is likely to exclusively contact the peptide (Kaiser, et al., 2005; Kaiser, et al., 2008; 
Sullivan, et al., 2008) This kind of interaction appears to enable the maximal ability to recog-
nize slight peptide-differences (Hoare, et al., 2008). 
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1.3.3	CD94/NKG2	receptor	signaling	and	membrane	dynamics
CD94/NKG2A and CD94/NKG2B comprise the inhibitory NKG2 receptors. Dimerization of 
CD94 or the splice variant CD94-T4 lead to functional receptors recognizing the cognate ligand 
HLA-E. Preferential association of CD94-T4/NKG2B and CD94/NKG2A is probably due to 
the absence of a stem region in both NKG2B and CD94-T4 (Lieto, et al., 2006). Two ITIM 
motifs on the intracellular NKG2 part facilitate, upon phosphorylation, binding of SHP-1 and 
SHP-2 phosphatases which suppress activating responses (Kabat, et al., 2002).  Perturbing the 
actin cytoskeleton–dependent recruitment of activating receptors to lipid rafts, as described in 
chapter 1.1.2, is an important mechanism by which NKG2A and B interfere with NK cell ac-
tivation. To maintain a continuous supply for interaction with HLA-E expressing cells, CD94/
NKG2A receptors recycle between the cell membrane and the cytoplasm independent of ligand 
binding or resulting inhibitory signaling in an active cellular process that requires cytoskeletal 
rearrangement (Borrego, et al, 2002). 
CD94/NKG2C and CD94/NKG2E/H lack ITIM motifs on their intracellular part, instead they 
have a charged lysine residue in the tansmembrane region that noncovalently associates with 
the ITAM bearing DAP12 adaptor molecule. For efficient cell surface expression, association 
of all three components, the CD94 and NKG2 receptor chains as well as the DAP12 molecule, 
is necessary (Lanier, et al., 1998; Bellon, et al., 1999). In contrast to inhibitory receptors, aggre-
gation and activation of activating CD94/NKG2 requires an intact cytoskeleton and ATP. PYK-
2 kinase, microtubule organizing center (MTOC) and paxillin are recruited to the site of target 
cell contact to permit an activating synapse (Borrego, et al, 2002). MAPK was also shown to 
be involved in the activating signaling pathway (Carretero, et al., 2000). Like CD94/NKG2A, 
also CD94/NKG2C is a long-lived receptor that shuffles between the cell membrane and the 
Figure	1.7	Interaction	of	NKG2A	with	the	HLA-E/peptide	complex
Schematic view of HLA-E/peptide and CD94/NKG2A crystal structure. Acetic regions (red) 
interact with basic regions (blue) with an affinity dependent on the bound peptide (green, 
HLA-G leader peptide is shown) (Sullivan, et al., 2008).
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cytoplasm. Protein transport inhibitor Brefeldin A treatment interferes with CD94/NKG2C but 
not CD94/NKG2A trafficking indicating that different mechanisms are involved (Borrego, et 
al., 2002). 
An exception among the NKG2 protein family is NKG2F. It has a truncated extracellular do-
main, contains a positively charged transmembrane residue as well as an ITIM-like structure on 
its intracellular domain. Expression is limited to intracellular compartments which is likely due 
to its inability to associate with CD94. So far, the physiological role of NKG2F remains unclear 
(Kim, et al., 2004). 
1.3.4	CD94/NKG2	receptor	expression	and	function	in	PBL	subpopulations
We are only beginning to understand the molecular mechanisms controlling CD94/NKG2 ex-
pression. Regulation of the transcription from multiple starting sites and posttranscriptional 
mechanisms are suggested to play the major role and a variety of cytokines like IL-2, IL-15, 
IFN-α, and IL-21 was shown to be important for regulation and induction of CD94/NKG2 sur-
face expression (Borrego, et al., 2006). 
The majority of NK cells and subpopulations of T cells are the only PBL were these proteins are 
found, the inhibitory CD94/NKG2A constituting the predominant heterodimer. The functions 
exhibited by CD94/NKG2 proteins are dependent on the cell type:
Although co-activation of other receptors might, as described above, be necessary, CD94/NKG2 
receptors represent largely independent, competent recognition units on natural killer cells that 
Figure	1.8	NKG2	receptors,	adaptors	and	signaling	motifs
Inhibitory NKG2A carries signaling motifs (ITIMs, immune tyrosine-based inhibitory mo-
tifs) on its intracellular part. Both activating NKG2-C and -D lack ITIMs but carry positively 
charged transmembrane residues which allow the association with adaptor proteins. DAP12 
carries ITAM (immune tyrosine-based activating motifs) and DAP10 contains the SH2 do-
main binding amino acid sequence YxxM.
(Figure adapted and reprinted by permission from Macmillan Publishers Ltd: [Molecular Im-
munology] (Borrego, et al., 2001), copyright (2001))
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transmits information about “self” and “non-self” in order to control killer-cell activation. By 
contrast, on T cells, CD94/NKG2 and other natural killer cell receptors (NKRs) are likely to act 
mainly as co-stimulatory molecules either supporting or suppressing T cell receptor mediated 
signaling. Differential expression of adaptor proteins and association with alternate adaptor 
molecules is a possible explanation for this unusual duplicity in function in innate and adaptive 
immunity (Snyder, et al., 2004). 
Mainly CD8+, gd TCR+ and D1d-restricted CD4– CD8– or CD4+ CD8– T cells (NKT) but also 
some CD4+ T cells express NK cell receptors like KIR and NKG2 (Mingari, et al., 2005; Til-
burgs, et al., 2009). NKG2A expression was found to be a clonal feature of cytotoxic T-lym-
phocytes (CTL) and T cell receptor (TCR) antigenic specificity seams to dictate its expression 
(Jabri, et al., 2002). Inconsistent reports exist about the function of CD94/NKG2A on CD8+ 
T cells: CD94/NKG2A was found to be either sufficient (Malmberg, et al., 2002; Mingari, et 
al., 1998) or insufficient (Romagnani, et al. 2002; Miller, et al., 2002) for inhibition of T cell 
receptor mediated signaling. Conflicting results exist also about CD94/NKG2 expression on 
CD4+ T cells. Whereas some observed CD94/NKG2 only on Th1 cells, which provide cytokine-
mediated “help” to cytotoxic T cells (Meyers, et al., 2002; Graham, et al., 2007), others reported 
expression by both Th1 and Th2 (which provide B-cell help) upon CD3-mediated activation 
but an impact of CD94/NKG2A stimulation on cytokine production only for Th1 (Romero, et 
al., 2001).  
Taken together, although many open questions remain, increasing evidence suggests that in-
hibitory and activating CD94/NKG2 receptors play an important role not only for NK cells but 
also for the regulation of T cell responses to self antigens and viral infections (Pederson, et al., 
2002; Mingari, et al., 2005) 
1.4	Human	peripheral	blood	T	cells	expressing	“natural	killer	cell	receptors”
The expression of receptors, originally found on NK cells, by T cells is dependent on the de-
velopmental stage, activation state, and genetic background of the cells. The term NKT cells 
is often used to refer to these cells but a clear definition is still missing which makes the usage 
misleading. Basically, one can distinguish between three subpopulations of T cells expressing 
NK cell receptors: “Conventional” T cells characterized by the expression of ab T cell receptor 
(abTCR) (1), “non-conventional” T cells harbouring either gdTCR (2) or a semi-invariant TCR 
comprised of an in-frame rearranged Vα24-Jα18 and a b chain (from a restricted repertoire) 
which makes them CD1d restricted (3). The invariant TCR of the latter precisely defines them 
and here they will be referred to as iNKT cells whereas (1) and (2) are named NKR+ ab T cells 
and NKR+ gd T cells, respectively (Matsuda, et al., 2001; Godfrey, et al., 2004; Mingari, et al., 
2005; Wakao, 2009). The receptors found include amongst others LIR1 (CD85j), CD94/NKG2 
and KIR (Mingari, et al., 2005; Tilburgs, et al., 2009; Kulkarni, et al., 2008) with most research 
dealing with expression of the inhibitory isoforms. 
30
1.4.1	NKR+	ab T	cells
NKR+ ab T cells include CD4+ and CD8+ cell though the majority has a CD8+ phenotype. KIR+ 
cells of both subsets were shown to accumulate with age and are enriched for effector memory 
cells (not expressing CCR7, CD27, and CD28) suggesting a function during effector memory 
cell responses (van Bergen, et al., 2004; Anfossi, et al., 2001). The same was found for LIR1+ 
CD8+ but not NKG2A+CD8+ (Anfossi, et al., 2001). The mechanisms governing NKR receptor 
expression are yet to be defined though it is clear that the factors influencing different NKR can 
be distinct (Vivier & Anfossi, 2004).  
So far, the functional consequence of NKR on ab T cells is unclear. For KIR, it is reported 
that expression may protect against activation-induced cell death of memory T cells and their 
expression could influence peripheral tolerance (Ugolini, et al., 2001; van Bergen, et al., 2004). 
Cross-linking of activating KIR on CD4+ in addition to TCR signaling and absence of inhibitory 
KIR, activated the cells for proliferation which hints a function during initiation and for sustain-
ing an immune response but also opens the possibility for a role in autoreactivity (Mandelboim, 
et al., 1996; Namekawa, et al., 2000). Inhibitory KIR or LIR1 co-ligation with TCRs on CD8+ 
T cells was reported to impair cytoskeletal reorganization required for TCR signaling and to 
downregulate cytotoxicity and cytokine production (Vivier & Anfossi, 2004). CD8+ T cells can 
express  NKG2D and binding of the ligand MICA was shown to activate them (Bauer, et al., 
1999). For CD94/NKG2 receptor expression and function see chapter 1.3.4.
Importantly, expression of NKR on T cells does not necessarily make them more or less effi-
cient effector cells because the efficacy of an inhibitory NKR signaling depends on the intensity 
of a simultaneously occurring activating signal (Vivier & Anfossi, 2004). 
1.4.2	iNKT
This subset makes up less than 0.1% of PBL in healthy human subjects and are composed of 
CD4+, CD8 + and double negative cells with implications for distinct physiological functions 
because of differential cytokine secretion and unequal NK-cell as well as chemokine receptor 
expression (Lee, et al., 2002; Godfrey, et al., 2004). The ligand for their T cell receptor, CD1d, 
is mainly expressed on antigen presenting cells like DC, macrophages and B cells which quali-
fies theses cells as potential primary interaction partners (Lee, et al., 2002). CD1 molecules are 
constituted, similar to MHC class I, of a heavy chain associated with b
2
m light chain. All four 
CD1 isoforms expressed by humans present lipid antigens to T cells. CD1d has only distant re-
lation to CD1a, b and c according to sequence homology (Vincent, et al., 2003). Self or foreign 
lipid antigens, loaded onto hydrophobic antigen binding clefts of CD1d are recognized in a yet 
poorly understood manner. However, this interaction enables recognition of antigens derived 
from microbes, other parasites and some types of cancer (Borg, et al., 2007; Kronenberg & 
Kinjo, 2009). Both “helper” and “effector” functions are carried out by the various subsets of 
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iNKT cells. The capacity for cytolytic activity and regulation of DC, NK and T cell activation 
denote their importance at the crossroad of innate and adaptive immunity even though adap-
tive functions are thought to dominate (Lee, et al., 2002; Vincent, et al., 2003; Minami, et al., 
2005). Occasional promotion of undesirable immune responses like allergy, atherosclerosis and 
autoimmune diseases corroborate the importance of iNKT and signify broad clinical potential 
(Godfrey & Kronenberg, 2004). The NK cell receptors CD94/NKG2A and 2B4 are almost 
exclusively expressed by CD4 negative iNKT whereas CD161 is highly expressed by all iNKT 
cells (Lee, et al., 2002; Kim, et al., 2002). It was recently shown that KIR are found on iNKT at 
frequencies usual for T cells and that allogeneic activation of iNKT requires KIR (Patterson, et 
al., 2008). iNKT are bona fide ab T cells but comprise only a very small fraction with still little 
knowledge about their basic function available. Most work about NKR expression on T cells 
distinguishes only between CD4 or CD8 expression on T cells. 
1.4.3 gd	T	cells
Like iNKT cells, this subset appears to locate between the innate and adaptive immune system. 
The g and d chain of the TCR are variable and so is the antigen specificity of different TCR di-
mers (Casetti & Martino, 2008). Most gd T cells do not express CD4 and CD8 and are found in 
epithelial and lymphoid tissues and blood, where they comprise 1-5% of lymphocytes (Carding 
& Egan, 2002). gd T cells can be divided in different functional subsets according to their allelic 
TCR composition. A wide array of antigens can be recognized due to MHC unrestricted recog-
nition that does not require processing of the antigen (Carding & Egan, 2002). They recognize 
bacterial metabolites (phospho or aminoantigens), virus antigens, tumor antigens, glycolipids 
in the context of CD1, and stress-induced MHC class I related molecules (like MIC family 
proteins) and exert cytolytic activity and production of cytokines like INF-g and T
H
1 cytokines 
(Gober, et al, 2003; Münz, et al., 2005). A subset of gd T cells is found to be CD1c restricted 
but the majority of gd T cells in blood carries the Vγ9–Vδ2 TCR. After birth, the TCR variety 
progresses towards oligoclonality reaching more than 97% of cells in blood having the Vγ9 
and Vδ2 rearrangements until the age of 6-10 (Spada, et al., 2000; Carding & Egan, 2002). 
Phosphoantigens from a wide spectrum of microorganisms were found to be recognized by this 
T cell subset but also other non-phosphoantigens. Similar to toll-like receptors, non-peptide 
antigens are scanned by the gd TCR in order to check the environment for conserved metabolic 
signatures and to recognize infections and “abnormal self” (Poupot & Fournie, 2004). Very 
little knowledge exists about NKR on gd T cells. MHC class I inhibitory receptor expression 
(KIR, but mainly NKG2A) was shown to functionally inhibit gd T cells upon ligand binding, 
but expression of inhibitory NKR correlated with the potential for strong lytic activity (Halary, 
et al., 1997; Bakker, et al., 1998).
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1.5	Human	Cytomegalovirus	(HCMV)
1.5.1	Classification,	structure	and	evolution
HCMV belongs to the herpesviruses (Human herpesvirus 5 (HHV-5), genus Cytomegalovirus, 
subfamily Betaherpesvirinae, family Herpesviridae), which are among the largest and most 
complex of viruses (Sinclair & Sissons, 2006; Davison, 2002). The huge family of herpesvi-
ruses is found in numerous species ranging from mollusks to vertebrates and humans. Long-
standing coevolution with their host leads to a narrow range of species-tropism with most of the 
120 yet identified species (Davison, 2002) being associated with a single host species. Because 
herpesviruses evolve with their hosts they also suffer extinction with them (Davison, 2002; 
Tischer & Osterrieder, 2009). Virion structure, antigenic and biological properties and DNA 
sequence comparison was used to identify members of the Herpesviridae and to subclassify 
them into the families a-, b-, and g-Herpesviridae with CMV belonging to the second (Davison, 
2002).
The double stranded DNA genome of HCMV contains repetitive elements flanking two unique 
sequence-regions termed unique short (US) and unique long (UL). The genome exceeds 235 
kb, with the potential to encode over 220 proteins, packaged in an icosahedral protein struc-
ture, the capsid, which is enveloped by a proteinaceous matrix (the tegument). A lipid bilayer 
envelope with numerous viral glycoproteins completes the 200 to 300 nanometer sized virion 
(Griffiths & Grundy, 1987; Greijer, et al., 2000; Crough & Khanna, 2009). 
Figure	1.9	HCMV	virion	structure	
Typical structure of herpesviruses with lipid-envelope embedded glycoproteins and an icosa-
hedral capsid containing the viral DNA. (http://expasy.org/viralzone/all_by_protein/180.
html)
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1.5.2	Epidemiology
HCMV can be transmitted person-to-person via saliva, tears, urine, stool, semen, and breast 
milk, sexual contact, placental transfer, blood transfusion, solid-organ transplantation, or he-
matopoietic stem cell transplantation (Sia & Patel, 2000). De novo infection with CMV appar-
ently occurs throughout the lifespan at a rate of around 0.5–1% per year up to the age 60–65. 
(Pawelec, et al., 2009). Studies done in the United States population revealed a seroprevalence 
of CMV in those aged 80 years or older of more than 90%, the mean age of infection being 28.6 
years. On average, one infected person transmitted the virus to nearly two susceptible people 
(Staras, et al., 2006; Colugnati, et al., 2007). 
1.5.3	Pathology
Immunocompetent patients usually have no symptoms during primary infection and reacti-
vation. Mainly diagnosed are mononucleosis with fever, myalgia, adenopathy, splenomegaly 
(Colugnati, et al., 2007; Crough & Khanna, 2009). 10% of congenitally infected children are 
symptomatic at birth and of those who are asymptotic, 10-15% will develop symptoms over 
month or years. Among this group, CMV is a leading cause of hearing loss, vision loss, and 
mental retardation (Colugnati, et al., 2007). Aside of that, the main problems CMV is causing is 
as a serious opportunistic infection of immunocomprimised patients. Although the introduction 
of highly active antiretroviral therapy (HAART) for HIV treatment, resulting in decreased im-
mune suppression, seriously reduced HCMV-associated diseases, it continues to be problematic 
and was suggested to accelerate the progress of AIDS and death. In solid organ transplantation 
(SOT) recipients, HCMV is the major infectious pathogen, effecting both graft survival and 
causing morbidity and mortality of the patient (Crough & Khanna, 2009). Similarly, in patients 
obtaining hematopoietic stem cell transplantation, HCMV is a major source of complications, 
associated with chronic graft-versus-host disease and increased risk of secondary bacterial and 
fungal infections (Boeckh & Ljungman, 2009). Depending on the conditions of CMV activa-
tion, clinical symptoms of HCMV disease vary, with febrile illness with leukopenia and mal-
aise, multi-organ disease including gastroenteritis, pneumonitis, retinitis, and hepatitis being 
just a few examples (Crough & Khanna, 2009).
1.5.4	HCMV	life	cycle
After a primary infection, CMV is able to establish a latent, life-long infection with spontane-
ous, periodic reactivation (Colugnati, et al., 2007; Crough & Khanna, 2009). In vivo, CMV-
derived DNA was found in monocytes, macrophages, neutrophils, lymphocytes and endothe-
lial cells. (Sia & Patel, 2000) During HCMV outbreak the cellular tropism is wide including 
endothelial cells, various leukocyte populations, epithelial cells, hepatocytes, smooth muscle 
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cells, and fibroblasts (Sinzger, et al., 1995; Razonable, 2008) whereupon the organ distribution 
is stunning: For example, all tested organs (adrenal gland, bone marrow, diencephalon, heart, 
kidney, liver, lung, pancreas, placenta, small bowel and spleen) were found to carry HCMV 
in case of a congenitally infected neonate (Bissinger, et al., 2002). The mechanism where and 
how latency is established remains to be elucidated. The discovery that hematopoietic precur-
sors (CD34+ cells) isolated from bone-marrow carry CMV and pass it over to monocytes (but 
not B- and T- cells) during differentiation, maybe as episomal molecules, hints at a possible 
mechanism (Sinclair, 2008).
Following CMV infection, the viral genome is expressed sequentially. During the first two 
hours, the immediate early (IE) genes are expressed followed by the early (E) (< 24 hour) and 
late (L) (> 24 hour) genes (Stinski, 1978). While CMV is known as a slowly replicating virus, 
in vivo analysis revealed that HCMV replication is a highly dynamic process and under permis-
sive conditions, the doubling time in blood likely takes about one day (Emery, et al., 1999). 
After interaction of viral glycoproteins with cell surface receptors leading to attachment of the 
virus, penetration into a target cell occurs. The nucleocapsid is released into the cytoplasm and 
subsequently translocated to the nucleus where the viral DNA is released. Expression of IE 
genes starts inducing viral DNA transcription and replication. Viral proteins are imported from 
the cytoplasm to the nucleus and the capsid reassembles, encapsulating the CMV genome. After 
nuclear egress, assembly with the envelope in the cytoplasm and virion release by exocytosis 
completes the CMV life-cycle (Crough & Khanna, 2009).
Figure	1.10	HCMV	life	cycle	
Upon HCMV infection, the capsid is released to the cytoplasm and subsequently translo-
cated to the nucleus where the viral DNA is released, inducing viral gene expression. Viral 
proteins, previously translated and imported to the nucleus, encapsulate the replicated viral 
DNA. After nuclear egress, the capsid is enveloped and the fully assembled virus gets exocy-
tosed, resulting in free HCMV (Crough & Khanna, 2009).
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1.5.5	HCMV	immune	modulation	of	cytotoxic	lymphocyte-mediated	responses
Among the herpesviruses, CMV encodes the greatest number of genes committed to altering 
magnitude and quality of both innate and adaptive immune responses. The mechanisms are 
diverse including (but not restricted to) molecular mimicry of cell surface receptors, cytokine 
homologues and inhibition of apoptosis (Miller-Kittrell & Sparer, 2009). 
1.5.5.1 Modulation of HLA class I expression
The ability of the immune system to monitor “self” and recognize pathogens with the same mo-
lecular system makes it a tightrope walk for CMV to reduce MHC class I expression to escape 
from cytotoxic T cell responses but then keeping sufficient MHC class I surface expression to 
prevent “missing self” responses by NK cells.
A multitude of viral unique short (US) proteins (US2, US3, US6, US10, US11) interfere by 
concerted action with MHC class I formation, transportation and expression, using mecha-
nisms like retention of fully assembled proteins in the ER, redirecting nascent MHC class I 
heavy chains to the cytosol for degradation and inhibiting TAP-dependent protein translocation 
to the ER. (Lin, et al., 2007) At the same time, the non-classical HLA-E molecule is retained 
on the surface: The leader sequence of HCMV glycoprotein UL40 contains exactly the same 
peptide as is derived from HLA-C and assembled with HLA-E. Loading of the virus-derived 
peptide by a TAP independent mechanism enables CMV to not only stabilize but upregulate 
surface expression of HLA-E which was found to protect against cytolysis by NKG2A+ NK 
cells (Tomasec, et al., 2000). To further compensate the MHC class I downregulation, HCMV 
encodes the MHC class I homologues gpUL18 and gpUL142. The better characterized UL18 
was shown to associate with b
2
-microglobulin, bind a mixture of endogenous proteins with 
similar characteristics to those that bind HLA class I and it is a ligand for the inhibitory ILT2 
(CD85j) bound with >1000-fold higher affinity than host MHC-class I (Chapman, et al., 1999; 
Wills, et al., 2005).
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1.5.5.2 Modulation of NKG2D ligand (NKG2DL) surface expression
Immunosurveillance of HCMV includes upregulation of ligands for the activating NK cell 
and co-activating T cell receptor NKG2D: MICA, MICB, UL16-binding proteins (ULBP1-
4), RAET1G and RAET1E (Eagle & Trowsdale, 2007; Wilkinson, et al., 2008; Jonjic´, et al., 
2008). It is therefore no surprise that HCMV has several immunoevasion strategies aimed at 
NKG2D to counteract the potent ligand-upregulating action of particularly its immediate early 
(IE) proteins (Wilkinson, et al., 2008). So far, two proteins and a micro-RNA were identi-
fied to act on the prevention of cell-surface expression of NKG2DLs: UL16 retains MICB, 
UL16BP1 and UL16BP2 in the endoplasmatic reticulum (ER) (Welte, et al., 2003; Wu, et al., 
2003; Wilkinson, et al., 2008) whereas MICA expression is impeded by UL142 (Chalupny, 
et al., 2006). The HCMV encoded micro-RNA miR-UL112 selectively downregulates MICB 
expression (Stern-Ginossar & Elefant, 2007). Cooperative targeting of NKG2DL surface ex-
pression through protein- and miRNA-mediated mechanisms may thwart NKG2D mediated 
“stress-signaling” during viral infection. 
1.5.5.3 Modulation of the cytokine and chemokine system
The homologue for the immunosuppressive cytokine IL-10 (cmvIL-10) binds the cellular IL-10 
receptor with the capacity to induce an anti-inflammatory response. Cmv-IL-10 was shown to 
have a similar antiproliferative capacity as cellular IL-10 (Spencer, et la., 2002). UL147 mimics 
Figure	1.11	Modulation	of	HLA-E	surface	expression	by	HCMV	
The HCMV encoded US6 protein prevents TAP-dependent protein translocation to the ER, 
which reduces MHC class I surface expression due to the lack of MHC-binding peptides. 
To counteract a “missing self” response, gpUL40 derived peptides, which reach the ER in a 
TAP-independent manner, bind to HLA-E, driving its surface expression (Wilkinson, et al., 
2008).
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host IL-8 and binds with high affinity to the cognate receptor CXCR2. The beneficial effect of 
CXCR2 signaling could either be disruption of normal cell migration patterns or attraction of 
lymphocyte subsets not capable to efficiently clear virus (Penfold, et al., 1999). From the four 
HCMV chemokine receptor homologues, US28 is the best characterized. It is most similar to 
CCR1 and binds the CC chemokines CCL2 (MCP-1), CCL3 (MIP-1a), CCL4 (MIP-1b), CCL5 
(RANTES) and CCL7 (MCP-3) but also CX
3
CL1 (fractalkine). Constitutive internalization of 
US28 with bound chemokines could lead to immune modulation by the removal of the chemo-
kines from the cellular environment. US28 is also a functional receptor mediating downstream 
signaling via G-proteins, eliciting Ca2+ mobilization and MAP kinase (ERK2) activation. The 
utilization of cellular G proteins could manipulate cellular cytokine-mediated responses to the 
benefit of CMV (Billstrom, et al., 1998; van Cleef, et al., 2006). Another mechanism to block 
chemokine signaling is to bind and occupy them in solution as found for the secreted RANTES 
decoy receptor US21.5 (Wang, et al., 2004).
1.5.5.4 Other important mechanisms supporting HCMV immunoevasion
Antibody-mediated immunity is inhibited by the expression of two FcR binding proteins, which 
may protect from ADCC and complement activation. The incorporation of the cellular proteins 
CD55 and CD59 in the virion and upregulation of these proteins on the host cell surface pro-
tects virion and cell from complement-mediated lysis (Miller-Kittrell & Sparer, 2009). To delay 
the death of HCMV infected cells, at least two anti-apoptotic proteins directly interfering with 
the apoptotic signaling pathways were found to date (Goldmacher, et al., 2005).  
Collectively, all these manipulative strategies of CMV exceed the capabilities of the human host 
to prevent or clear an infection, but as long as the immune system is not debilitated, coevolution 
has led to mechanisms which, in the majority of cases, result in harmless coexistence enabled 
through “arranged” immunoevasion and immunosurveillance. Even so, HCMV is a serious 
pathogen that puts a burden on the immune system and despite intense research, we still miss 
a treatment that can shift the balance towards the benefit of the host, enough to clear HCMV.
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1.6	Aims
Surface protein expression is a major aspect influencing the property of cells and has been suc-
cessfully used to identify functionally distinct subsets. There is increasing evidence that CD94/
NKG2 receptors, expressed on NK and T cells, are important during various immune reactions 
but to date, it is not clear to whcih extent these receptors cotribute to cellular functions and if 
their expression defines heterogeneous lymphocyte populations. The amis included:
1. To define subpopulations characterized by the expression pattern of CD94/NKG2 receptor 
isoforms and to assess the frequency and distribution of CD94/NKG2 receptors within isolated 
PBMC of different individuals.
2. To correlate CD94/NKG2 receptor expression with known NK and T cell subpopulations.
3. To analyze the mitotical and functional activity of CD94/NKG2 receptor-expressing cells 
upon encounter of target cells expressing the cognate ligand HLA-E and in the context of CMV 
infection.
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2.	Materials	&	Methods
2.1	Cell	culture	techniques
2.1.1	Cell	lines	and	primary	cells
LCL 721.221. (MHC class 1a deficient EBV-transformed B lymphoblastoid cell line kindly 
provided by Prof. Miguel Lopez-Botet, Universitat Pompeu Fabra, Barcelona), K562 (human 
myelogenous leukemia cell line), MRC-5 (Human embryonic lung fibroblasts obtained from 
American Type Culture Collection (ATCC) or kindly provided by Prof. Hartmut Hengel, Hein-
rich Heine Universität, Düsseldorf) and isolated PBMC were maintained in RPMI 1640 me-
dium (Sigma-Aldrich) supplemented with 10% heat inactivated fetal calf serum (FCS, Sigma-
Aldrich), 2 mM L-glutamine (200 mM solution, Sigma-Aldrich), 100 U/ml penicillin G, 100 
μg/ml streptomycin, 0.25 μg/ml fungizone (Pen/Strep Fungizone Mix, Bio Whittaker) and 1 
mM sodium pyruvate (Sigma-Aldrich) (referred to as complete medium). Medium was sterile-
filtered (0.22 mm pore size Stericup® Filter Units, Milipore) after addition of supplements. For 
TB40 stock preparation (2.1.5), MRC-5 cells were cultured in DMEM / High Glucose medium 
(Fisher Scientific) supplemented in an analogous manner.
LCL 721.221.AEH cells (HLA-E*0101 transfected, kindly provided by Prof. Miguel Lopez-
Botet, Universitat Pompeu Fabra, Barcelona) were cultured in complete RPMI 1640 supple-
mented with 200 mg/ml hygromycin B (Invitrogen). 
Cell lines were screened and shown to be negative for Mycoplasma contamination by poly-
merase chain reaction (mycoplasma detection kit, Roche)
All cells were maintained in a humidified cell-culture incubator at 37°C in 5% CO
2
 (referred to 
as standard conditions)
HUVEC (human umbilical vein endothelial cells, isolated in our laboratory) were seeded onto 
gelatine-coated tissue culture flasks or plates in M199 medium (Lonza) supplemented with 20% 
heat inactivated FCS (Sigma-Aldrich), 100 U/ml penicillin G, 100 μg/ml streptomycin, 0.25 
μg/ml fungizone (Pen/Strep Fungizone Mix, Bio Whittaker), 12 µg/ml Endothelial Cell Growth 
Supplement (PromoCell), 2 mM L-glutamine (Sigma) and 5 U/ml heparin (Fisher Scientific) 
(referred to as complete medium). Medium was sterile-filtered (0.22 mm pore size Stericup® 
Filter Units, Milipore) after addition of supplements. 
2.1.2	Isolation	of	peripheral	blood	mononuclear	cells	(PBMC)
PBMC were obtained from fresh heparinized whole peripheral blood of healthy donors by 
centrifugation on Ficoll-PaqueTM PLUS (Amersham) using standard procedures. All steps are 
done on ice or at 4°C using pre-cooled solutions. In brief, peripheral blood is diluted 1:1 with 
Calcium- and Magnesium-free Phosphate Buffered Saline (PBS, Bio Whittacker) and 30 ml 
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cell suspension is carefully overlaid on 15 ml Ficoll-PaqueTM in a 50 ml FalconTM tube (BD). 
After 30 min centrifugation at 700 x g without brake, the buffy coat is transferred to a fresh tube 
and diluted 1:2 with PBS. The cell suspension is centrifuged at 250 x g for 10 min, the pellet is 
resuspended in 50 ml PBS and centrifuged again 10 min at 100 x g (platelets stay in solution). 
According to the manufacturer, this procedure leads to isolation of lymphocytes and monocytes 
whereas other components (including granulocytes, erythrocytes & platelets) are largely re-
moved. PBMC are resuspended in complete RPMI 1640 medium or FACS buffer (see below) 
for in vitro culture or analysis, respectively. 
2.1.3	Magnetic	activated	cell	sorting	(MACS)
NK cells were negatively selected from PBMC by magnetic activated cell sorting (MACS) 
using an NK Isolation Kit (Miltenyi Biotec, cat. 130–092–657) following the manufacturer’s 
instructions. In brief, PBMC are incubated with a mix of biotin-labeled antibodies recognizing 
proteins expressed on various immune cells but not on NK cells. Incubation with biotin-binding 
magnetic beads allows to remove antibody-bound cells by loading onto a column placed in a 
magnetic field. Magnetically labeled cells are retained and NK cells remain in the flow-through. 
2.1.4	Co-culture	of	PBMC	with	LCL	721.221.	cells
LCL 721.221. or 721.221.AEH cells were irradiated at 30 gray at a cell density ≤ 107 per ml. 
721.221.AEH were transferred to medium without hygromycin B at least 24 hours before irra-
diation. 3 x 106 freshly isolated PBMC were incubated alone or with 1 x 106 irradiated cells per 
well of a 24 well plate in complete RPMI 1640. The culture medium was partially exchanged 
every 2-3 days by carefully aspirating 50%, replacing it with fresh complete RPMI 1640 and 
resuspending the cells. Alternatively, cells were resuspended, split 1:1 and supplemented with 
fresh medium commensurate to the transferred suspension volume (therefore equalling 50% 
medium exchange).
2.1.5	Co-culture	of	PBMC	with	HCMV	infected	fibroblasts
HCMV infected and mock treated MRC-5 cells were co-cultured in 24-well plates using com-
plete RPMI 1640 medium. 24 hours post infection, 2 x 106 freshly isolated PBMC were added 
per well to the culture supernatant. The culture medium was partially exchanged every 1-2 days 
by carefully aspirating an equal portion of each well, replacing it with fresh complete RPMI 
1640 and resuspending the cells. Starting three days after the co-incubation, all cultures were 
supplemented with 10 international units (IU) recombinant human IL-2 (R & D Systems) per 
ml. 
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2.2	Working	with	HCMV
2.2.1	Infection	of	MRC-5	cells	and	HUVEC	with	HCMV
MRC-5 cells (passage 8-17) or HUVEC (passage 3-5) were seeded in tissue-culture plates in 
the respective complete medium (see 2.1.1) until 70 % confluence and infected with AD169 
(MRC-5) or TB40 (MRC-5, HUVEC) (both lab strains kindly provided by Prof. Hartmut Hen-
gel, Heinrich Heine Universität, Düsseldorf) by pipetting the virus-containing suspension in 
the cell culture supernatant using a multiplicity of infection (MOI) of 1, 2.5 or 5. Plates were 
centrifuged 2 x at 700 x g for 15 minutes at 37°C, turning the plates 180° in between the runs. 
Cells were incubated under standard conditions and after a total of 2 hours virus exposure, the 
culture supernatant got aspirated and replaced with fresh complete medium. Mock-treated cells 
were proceeded in parallel and received PBS instead of the virus-containing suspension.
2.2.2	Preparation	of	a	HCMV	(TB40)	stock
A confluent 6-well plate MRC-5 cells (passage 17) was infected with TB40 as described in 
2.1.4 with the exception that the virus-containing medium was not exchanged after 2 hours. 
Four days post infection, supernatant and cells (using a cell-scraper) were collected and trans-
ferred to two confluent T175 flasks MRC-5 cells (passage 17). After one week incubation, cells 
and supernatant were collected again and distributed equally to 21 confluent T175 flasks MRC-
5 cells (passage 11). Fresh medium (complete DMEM) was added if the medium-color turned 
towards orange. Nine days later, cells and supernatant were collected and centrifuged at  3500 x 
g for 20 min at 15°C to pelletize cells and debris. The supernatant was transferred to fresh tubes, 
centrifuged at 25 000  x g for 3 hours at 15°C (to pelletize the virus) and resuspended in 10 ml 
ice-cold PBS. A pre-cooled (-20°C) douncer was used to homogenize the suspension by care-
fully inserting and pulling out the pestle 20 times. The virus suspension was carefully overlaid 
on a 20 ml ice-cold sorbitol cushion (20% sorbitol in dH
2
O, 50 mM Tris ph 7.4, 1 mM MgCl
2
, 
100 µg/ml bacitracin (Sigma-Aldrich); sterile filtered) and centrifuged 1 hour at 60 000 x g at 
10°C. The pellet was resuspended in 3 ml PBS and homogenized with a douncer as described 
above. 20 or 30 µl aliquots were prepared and stored at -80°C.
2.2.3	HCMV	(TB40)	titration
MRC-5 cells were cultured in a 96 well flat-bottom plate until 90% confluence. The virus stock 
was pre-diluted 1:10 with medium and added to the wells in 10-fold serial dilution steps on a 
200 µl scale followed by 2 x 15 minutes centrifugation at 700 x g at 37°C. 72 hour post infec-
tion, the medium was removed and 100 µl methanol (-20°C) added per well to fix the cells. 
After 10 min incubation on ice, methanol was aspirated, the plate was air-dried and washed 
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once with PBS. For CMV detection, cells were incubated with a monoclonal mouse anti-CMV 
antibody-mix comprised of clones CCH2 (recognizing an early protein) and DDG9 (recogniz-
ing an immediate early protein) (Dako, kindly provided by Prof. Hartmut Hengel). The primary 
antibody-mix was diluted in PBS with 1% skim milk, added to the fixed cells and incubated 
for one hour at room temperature. After washing twice with PBS, cells were incubated with 
horseradish peroxidase (HRP) conjugated sheep anti-mouse IgG antibody (GE Healthcare, cat. 
NA931V). Antibody-bound cells were detected using 3-amino-9-ethyl-carbazol (AEC, kindly 
provided by Prof. Hartmut Hengel) which reacts with HRP, producing a red-brown precipitate. 
The reaction was stopped by removal of the substrate solution and washing once with PBS as 
soon as stained cells were observed. CMV infected cells were counted and the number of infec-
tious units (PFU, plaque forming units) per ml virus stock was calculated. Titration and detec-
tion was performed in triplicates.
2.2.4	CMV	infection	status	of	PBMC	donors
Blood samples were taken into non-heparinized, citrate-containing tubes to prevent coagula-
tion and to stabilize serum antibodies. Test of CMV infection state of each donor was per-
formed by the “Clinical Institute for Virology” of the “Medical University of Vienna” via 
PCR and CMV-IgG and -IgM ELISA.
2.3.	Flow	cytometry
2.3.1	Preparation	of	cells	
Adherent cells (HUVEC, MRC-5) were detached by washing once with PBS and incubation 
with trypsin-EDTA (Sigma-Aldrich). The action of trypsin was stopped by the addition of tryp-
sin-inhibitor (Sigma-Aldrich) or FCS followed by resuspension of the cells with culture me-
dium.
Cells growing in suspension (721.221, 721.221.AEH, K562, PBMC) as well as suspended ad-
herent cells were transferred to 50 ml FalconTM tubes and centrifuged 10 min 200 x g at 4 °C, 
washed once with ice-cold PBS and resuspended in ice-cold FACS buffer (PBS + 2% FCS + 
0.1% NaN
3
). 
To inactivate CMV, virus exposed (and mock-treated) cells were washed with PBS, incubated 
for 10 min on ice with CellFix (BD Biosciences), washed again and resuspended in FACS buf-
fer. 
Cells were counted in a haemocytometer and adjusted to 1-5 x 105 per 50 µl with FACS buffer.
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2.3.2	Monoclonal	antibodies
2.3.3	Antibody	staining	and	analysis	by	flow	cytometry
Cells and solutions are kept on ice and in dark throughout the entire procedure. 50 µl aliquots 
of suspended cells were transferred to 96-well V-bottom plates (Greiner) and incubated 10 
min with 2 µl Fc receptor blocking reagent (Miltenyi) followed by the addition of saturating 
concentrations of primary monoclonal antibodies (sell 2.2.2). For multicolor staining, dif-
ferentially fluorochrome-conjugated (APC, FITC, Fluorescein, PE) antibodies were simul-
taneously added to the samples. After 30 min incubation, 100 µl FACS buffer was added, 
cells were centrifuged 5 min at 600 x g and the supernatant was discarded. The pellet was 
resuspended in 150 µl FACS buffer, centrifuged again and finally resuspended in 25 to 100 µl 
FACS buffer (depending on the total cell number per sample) for analysis by flow cytometry. 
For indirect immunofluorescent staining with unlabeled primary antibodies, cells were subse-
quently incubated with a polyclonal, FITC labeled anti-mouse Ig antibody (Dako) using the 
same staining-procedure. A FACS Calibur machine (Becton Dickinson) was used for measure-
ment and Cell Quest Pro software (Becton Dickinson) for analysis. Cells were incubated for 
5 min on ice with 1 µl 7-amino-actinomycin D (7AAD, eBioscience) before measurement to 
examine the viability. 
Speciﬁcity (all human) Clone Conjugate Source
CD3 UCHT1 APC AbD Serotec
CD3 UCHT1 FITC Abcam
CD16 3G8 PE BD Biosciences
CD56 (NCAM) NCAM16.2 FITC BD Biosciences
CD62L (L-selectin) DREG-56 PE BD Biosciences
CD94 DX22 FITC AbD Serotec
CD107a (LAMP-1) H4A3 FITC BD Biosciences
CD158 (KIR) 180704 Fluorescein R & D Systems
CMV encoded proteins CCH2 and DDG9 Dako *
HLA-DR L243 PE BD Biosciences
HLA-E MEM-E/08 Abcam
MHC class I W6/32 *
NKG2A (CD159a) Z199 PE Beckman Coulter
NKG2C 134591 APC R & D Systems
NKG2C 134591 PE R & D Systems
NKp46 9E2/NKp46 APC BD Biosciences
APC, allophycocyanin; FITC, ﬂuorescein isothiocyanate; PE, phycoerythrin
* kindly provided by Prof. Hartmut Hengel, Heinrich Heine Universität, Düsseldorf. 
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2.3.4	Recombinant	human	Fc-FITC	staining
CMV infected and mock treated HUVEC and MRC-5 cells were stained with recombinant hu-
man Fc-FITC (Rockland, kindly provided by Prof. Hartmut Hengel, Heinrich Heine Univer-
sität, Düsseldorf) the same way as described for primary labeled antibodies with the exception 
that cells were not incubated with Fc receptor blocking reagent. 
2.4	CD107a	surface	mobilization	assay
CD107a (LAMP-1) is found on the cell surface of NK and T cells upon degranulation and its 
surface expression correlates with the cytolytic and/or cytokine producing activity (Betts, et al., 
2003; Alter, et al., 2004). 
Freshly isolated or co-cultured total PBMC or MACS sorted NK cells were used as effector 
cells and 721.221., 721.221.AEH and K562 as targets cells (“no target” control cells received 
medium). Effector (E) and target (T) cells were incubated in complete RPMI 1640 growth me-
dium at a ratio of E:T = 10:1 using ≥ 1 x 106 effectors per ml in 24 or 96 well plates (Greiner). 
Immediately after the start of the co-incubation, 20 µl FITC labeled anti-CD107a antibody (BD 
Biosciences) was added per ml culture medium. After 1 hour incubation in a cell culture incu-
bator at standard conditions (37°C, 5% CO
2
), 6 µg/ml monensin (Sigma-Aldrich) was added to 
prevent the degradation of reinternalized CD107a proteins in endocytic vesicles (Alter, et al., 
2004) and cells were incubated for an additional 5 hours. Finally, the cells were stained with 
APC or PE labeled monoclonal antibodies and analyzed by flow cytometry as described in 
chapter 2.3.
45
3.	Results
Nk cells are constituted by complex mixtures of cells expressing varying combination of NK 
receptors. Furthermore, NK receptors can be expressed on a fraction of T cells. In the first 
part of this work it was attempted to define subpopulations of NK and T cells distinguished by 
their expression of CD56 and the CD94/NKG2 heterodimeric receptors. The second part was 
aimed to functionally characterize these cell-subpopulations. 
3.1	Analysis	of	NKG2A	and	NKG2C	expression	within	PBL	subpopulations	
3.1.1	Lymphocyte	gating	and	identification	of	PBL	subpopulations	by	surface	protein	ex-
pression
Peripheral blood mononuclear cells (PBMC) were isolated from fresh heparinized whole blood 
by density gradient centrifugation after overlay on Ficoll-Paque. PBMC stained with fluores-
cent labeled antibodies specific for various surface proteins were analyzed using flow cytom-
etry. Cells were plotted in a forward (FSC) versus side (SSC) scatter dot-blot, which allows to 
electronically gate on the lymphocytic population because of their characteristic light scattering 
properties as described by Loken et al. (1990). FSC corresponds to cell size and SSC corre-
sponds to granularity. Cytometer settings, suitable to distinguish lymphocytes from monocytes 
do not allow to simultaneously display neutrophils, basophils and eosinophils because they are 
bigger and much more granular. The viability of isolated PBMC was confirmed by incubation 
with 7-amino actinomycin D (7aad) which stains dead and apoptotic cells (Philpott, et al., 1996) 
(Fig. 3.1). 
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Figure	3.1	Lymphocyte	gating	in	flow	cytometry	
PBMC are gated on the lymphocytic fraction (indicated in red) using a light scattering gate 
to distinguish them from monocytes (indicated in blue). Incubation with 7aad, which stains 
dead and apoptotic cells, is used to confirm cell viability. Fluorescent labeled antibodies en-
able to identify lymphocyte populations defined by surface protein expression as indicated in 
the right dot blot using APC labeled anti-NKp46 and a FITC labeled anti-CD56 antibodies.
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To distinguish PBL subpopulations, specific antibodies against CD3, CD56 and NKp46 were 
used. Natural killer cells (NK cells) are usually identified as being either CD3- and CD56+ or 
NKp46+ and CD56+. NKp46 alone is considered to be a specific marker for NK cells but func-
tional subsets can be defined by the pattern of CD56 expression. Because of that, the small 
population of NKp46+ CD56- NK-cells is not considered in the current studies unless otherwise 
noted (Fig. 3.2 A). Two major NK cell subpopulations defined by the strength of CD56 expres-
sion are referred to as CD56bright or CD56dim cells according to their strong or weak staining for 
CD56, respectively. The CD16 and CD62L expression patterns indicate a functional difference 
between these populations (see chapter 1.2.4) and confirm the appropriate use of gates to de-
termine the frequency of subpopulations and to analyze expression of other surface proteins 
within the subpopulations (Fig. 3.2 B). A small fraction of CD56+ cells co-expresses CD3, 
indicating that these cells belong to the T cells compartment and thus dividing CD56+ cells in 
an NK and T cell subset. The distribution of NK and T cells within PBL as well as the subsets 
defined by CD56 expression is shown in Table 3.1. The different cellular components of PBL 
varied between different individuals but the most prominent cells were T cells, regularly giving 
values of about 70% of PBL. On average, only 9% of T cells express CD56, making NK cells 
to the major CD56 expressing subset in most individuals, with the exception of donor 2.  NK 
cells typically comprise on average 16.5% of PBL with an high variation between individuals 
ranging from 4% to 24.5%.  
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Figure	3.2	Distribution	of	NK	and	T	cell	markers	on	PBL
A, To identify T cells and NK cells within lymphocytes, cells are stained with anti-CD3-APC 
and anti-CD56-FITC or anti-NKp46-APC and anti-CD56. NK cells are identified as being 
either CD3- CD56+  or NKp46+ CD56+. T cells are CD3+ and some also CD56+. B, C, CD56bright 
(15%, blue) and CD56dim (85%, red) NK cell subpopulations differentially express CD62L 
and CD16. CD56+ non-NK cells are removed by electronic gating using R1 indicated in (B). 
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3.1.2	Co-expression	of	CD94	with	NKG2	receptor	isoforms
NKG2A and NKG2C dimerize with the invariant CD94 chain in order to get expressed on the 
cell surface. The unusual appearance of the CD94+ NKG2+ cell population on the diagonal 
indicates that the amount of NKG2A or NKG2C on the cell surface correlates to a large extent 
with the amount of CD94, reflecting the cell surface co-expression as heterodimers (Fig. 1.2 A). 
It is not clear weather the 0.5% of cells found to express NKG2 isoforms without CD94 really 
exist or if they are artifacts due to an unspecific staining of the antibodies. The expression of 
NKG2A and NKG2C is not mutually exclusive as a small population expresses both receptors. 
Thus, by this analysis Nk cells can be subdivided in 4 subpopulations, a NKG2A+, a NKG2C+, 
a NKG2A+/NKG2C+ double positive and a double negative population. Other NKG2 receptor 
isoforms, such as NKG2E and NKG2H, which are thought to have to dimerize with CD94 in 
order to reach the cell surface, could only be form small separate subpopulations since usually 
the number of CD94 positive cells is close to the sum of NKG2A and NKG2C positive cells, as 
shown for a representative PBL donor in figure 3.3. However, as previously suggested (Brost-
jan, et al., 2002), it is possible that NKG2E and possibly also NKG2H might be co-expressed 
to a lower extent with the NKG2C subpopulation. Since specific antibody reagents for these 
NKG2 isoforms are still missing, this possibility can not be evaluated yet. 
T cells NK cells
Donor % of PBL % CD56- % CD56+ % of PBL % CD56 dim % CD56 bright
1 76.5 91.0 9.0 11 91.0 9.0
2 74 88.0 12.0 4 87.5 12.5
3 67 97.0 3.0 21 95.0 5.0
4 71 93.0 7.0 14 93.0 7.0
5 65 83.0 17.0 23 85.0 15.0
6 68.5 93.5 6.5 24.5 87.5 12.5
7 68 91.0 9.0 18 94.5 5.5
Mean 70 +/- 4 91 +/- 4.5 9 +/- 4.5 16.5 +/- 7 90.5 +/- 4 9.5 +/- 4
Table	3.1	Distribution	of	NK	and	T	cell	subpopulations	in	PBL
PBMC of 7 healthy donors are stained with specific antibodies against CD3 and CD56 to 
identify PBL subpopulations in flow cytometry.  NK cells are defined by NKp46 and CD56 
staining, T cells by CD3.
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Figure	3.3	Co-expression	of	CD94/NKG2A	and	CD94/NKG2C
PBMC were triple-stained with CD94, NKG2A and NKG2C specific antibodies. Analysis 
of PBL in flow cytometry shows co-expression of NKG2-A and -C with the invariant CD94 
chain. 
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3.1.3	NKG2A	and	NKG2C	expression	in	PBL	subpopulations
The expression of CD94/NKG2-A or -C by PBL is restricted to T and NK cells (Fig. 3.4) with 
NKG2A being the predominant receptor isoform in both fractions. The major cell type express-
ing NKG2 receptors are NK cells. This is true when considering the total cell number of CD94/
NKG2 expressing cells as well as the percentage of CD94/NKG2 expressing cells within the 
NK as compared to the T cell population. This seems to hold true as long as the PBL donor has 
usual NK cell numbers. Donor number 2, which had only 4% NK cells, was the only observed 
case where the majority of CD94/NKG2 expressing cells were T cells.
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Figure	3.4	NKG2A	and	NKG2C	expression	in	PBL	subpopulations
Exemplary PBL analysis of NKG2A and NKG2C expression on NKp46, CD3 and CD56 express-
ing cells. 
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Simultaneous staining of PBL with specific antibodies conjugated to different fluorochromes 
(APC, FITC, PE) allows to correlate the expression of proteins to each other. NK and T cell sub-
populations, defined by CD56 expression were analyzed for the distribution of CD94/NKG2-A 
and -C. Both isoforms show a preferential expression on CD56bright as compared to CD56dim NK 
cells and on CD56+ as compared to CD56- T cells (figure	3.5). This pattern was true for every 
donor investigated (n = 7), although the extent varied:
% CD56 bright NKG2A+ NK-cells : % CD56 dim NKG2A+ NK-cells = 1.8 +/- 0.3 (range: 1.5 - 2.3)
% CD56 bright NKG2C+ NK-cells : % CD56 dim NKG2C+ NK-cells = 4.9 +/- 3.6 (range: 3.0 - 12.5)
% CD56+ NKG2A+ T cells : % CD56- NKG2A+ T cells = 8.9 +/- 4.4 (range: 4.6 - 17.0) 
% CD56+ NKG2C+ T cells : % CD56- NKG2C- T cells = 9.0 +/- 7.6 (range: 2 - 24) 
The expression of NKG2A within the NK cells population was found similar for each donor 
whereas NKG2C shows much higher alterations with regard to the percentage of expressing 
cells. T cells expressing NKG2 isoforms were generally found to represent only a small sub-
population but the correlation with CD56 expression was strong. 
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Figure	3.5	CD56	expression	correlates	with	NKG2-A	and	-C	expression	on	NK	and	T	
cells
A, Exemplary PBL staining, indicating the gates used for the analysis of NKG2A and NKG2C 
expression within PBL subpopulations; CD56bright NK (dark red), CD56dim NK (pink), CD56+ 
(dark blue) and CD56- (light blue) T cells. Cells were triple-stained with CD3-APC, CD56-
FITC and NKG2A-PE or NKG2C-PE. B, Mean values and standard deviation of 7 donors 
analyzed for NKG2-A and -C expression. 
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Similar to the lectin-like NKG2 receptors, killer immunoglobin-like receptors are exclusively 
expressed on T and NK cells and comprise inhibitory and activatory members. Because of these 
similar properties, it was of interest to test, if NKG2 and KIR expression is linked. Figure 3.6 
shows one out of three PBMC donors analyzed. If no linkage between NKG2A and/or NKG2C 
and KIR expression takes place, one would expect that expression of NKG2-A and -C among 
KIR+ cells is as frequent as expression of NKG2A and -C among KIR- cells. The actually 
detected percentage of KIR+ NKG2-A+ or -C+ cells divided by the calculated theoretical per-
centage without linkage gives an “overrepresentation-factor” 1 would indicate neither positive 
nor negative correlation. For NK cells, the obtained factors were 0.5, 0.7 and 0.9 for NKG2A+ 
KIR+ cells and 1.1, 1.2 and 1.3 for NKG2C+ KIR+ cells, indicating that co-expression might be 
negatively correlated concerning NKG2A and positively concerning NKG2C. In contrast, for 
T cells both NKG2 receptors were found positively correlated with KIR expression. NKG2A+ 
KIR+ cells were 2.2, 3.1 or 5.7 times and NKG2C+KIR+ cells 11.4, 12.4 or 14.4 times more 
frequent than they would be expected to occur if expression would be random within the T cell 
population. 
3.1.4	 Amplification	 of	 CD94/NKG2	 receptor-expressing	 cell	 types	 upon	 co-culture	 of	
PBMC	with	HLA-E	expressing	cells
To investigate the influence of HLA-E, the ligand for CD94/NKG2 receptors, on T and NK cell 
growth and/or survival and receptor expression, we co-cultured PBMC with the LCL 721.221 
HLA class Ia-deficient lymphoma cell line (Shimizu et al., 1988) either transfected with HLA-E 
(221-AEH) or untransfected (221-wt) lacking HLA-E surface expression (Fig. 3.7). To moni-
tor the total PBMC cell number at various time points after co-culture, representative samples 
were taken and counted in a haemocytometer. From this the cumulative cell number (CCN) was 
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Figure	3.6	KIR	expression	on	T	and	NK	cells	
Exemplary PBL staining using anti-NKG2-A (or -C), anti-NKp46 and anti-KIR (recogniz-
ing KIR2DL2, KIR2DL3, KIR2DS2 and KIR2DS4) antibodies. NK cells are identified as the 
major KIR expressing subpopulation. To determine the correlation between KIR and NKG2 
receptor expression on T and NK cells, electronic gating on NKp46+ NK cells (R1) and non-
NK cells (R2) was used (see text for further details)
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calculated, which represents the amount of cells that would have accumulated without taking 
samples at a previous time-point (Fig. 3.8). Analyzing cells from six individuals, a general pat-
tern of cell expansion was observed: PBMC co-cultured with 221-wt cells expanded until day 
seven and then declined again. This early expansion was missing in 221-AEH co-culture, which 
led to a more delayed but then stronger cell proliferation starting around day 7 and continuing 
for 5 to 7 days. The lifespan of the proliferated cells was short, as a rapid drop in cell numbers 
occurred afterwards. If PBMC were cultured alone, hardly any proliferation was detectable. 
A  PBMC                  B  PBMC + 221-cells
C     721.221-wt cells D      721.221-AEH cells
HLA-E-FITC
co
un
ts
Figure	3.7	PBMC	co-culture	set-up
A, B, Freshly isolated PBMC alone (A) or mixed with irradiated 221 cells (B). C, D, confir-
mation of HLA-E expression on 221-AEH but not 221-wt cells. The primary unlabeled anti-
HLA-E (MEM-E/08) antibody was detected with secondary anti-IgG-FITC. 
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Figure	3.8	Growth	curves	of	PBMC	cultured	alone	or	with	221	cells
Cells were counted at various time points using a haematocytometer. A representative donor 
for six analyzed is shown.
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Figure	3.9	PBL	composition	and	expansion	upon	221-wt	and	221-AEH	co-culture
Isolated PBMC were co-cultured with 221-wt or 221-AEH cells and analyzed by flow cy-
tometry. A, B, composition of PBL subpopulations at day 7 (A) and day 13 (B) upon various 
culture conditions. C, D, Multiplication of PBL subpopulations at the peak of the cell count 
upon 221-wt (C) or 221-AEH (D) co-culture relative to day 0. Representative for four experi-
ments performed with one blood donor.
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Figure	3.10	Expansion	of	NKG2C	expressing	cells	upon	221-AEH	co-culture
A, Representative graph for PBMC of six donors cultured alone, with 221-wt or 221-AEH 
cells and analyzed regarding the expression of NKG2A and NKG2C. B, C, Composition of 
NKG2A and NKG2C expressing cells upon 221-AEH co-culture for 13 days for PBL of do-
nors showing both NK and T cell expansion (B) or only NK cell expansion (C).
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To determine the nature of the proliferating cells, analysis by flow cytometry was performed. 
The peak at day 7 following 221-wt co-culture seems to be due to a general proliferation stimu-
lus  for all cells of the lymphocyte fraction and was comparable for all blood donors. (Fig.3.9 
A & C) Whilst the amount of other cell types starts to decrease after day 7, NK cells seem to 
expand and/or survive until day 13 (Fig. 3.9 B).
A donor-dependent response was found for PBMC co-cultured with 221-AEH cells. Until day 
7, no difference between the donors was observed, but the cell expansion between day 7 and 
day 13 differed. Principally, two extreme donor-types showing either CD56+ T cell together 
with NK cell expansion (referred to as type 1 donors) or only NK cell expansion (type 2 do-
nors) could be distinguished. Because an expansion of CD56+ T cells was only detected upon 
co-culture with HLA-E expressing cells, and was not observed with 221-wt cells, we display 
the analysis focused on type 1 donors (Fig. 3.9 B). In line with previous reports by Guma et 
al., the most significant response takes place for NKG2C expressing cells (Fig. 3.9 D & 3.10) 
which were clearly preferentially expanded. Importantly, this response was found irrespective 
of the donor type indicating that both of the major CD94/NKG2 receptor expressing cell types, 
namely NK and CD56+ T cells (see Fig. 3.5), can be induced to proliferate as a result of HLA-E 
encounter. For exemplary type 1 donors, amplified NKG2C expressing cells belong to an equal 
extent of about 43% to NK or CD56+ T cells and about 13% can be detected in CD56 negative T 
cells. In contrast, NK cells constitute more than 90% of NKG2A expressing cells (Fig. 3.10 B) 
arguing for an inhibitory effect of NKG2A on T cell and in particular CD56+ T cell proliferation 
as CD56+ NKG2A+ T cells outnumber CD56+ NKG2C+ T cells in freshly isolated PBMC (see 
Fig. 3.5). The strong correlation of CD56 and NKG2C expression on T cells is further empha-
sized by the finding that cells from type 2 donors (which do not respond to HLA-E expressing 
cells with CD56+ T cell expansion) completely lack an expansion of NKG2C expressing T cells 
(Fig. 3.10 C).
3.2	Impact	of	CD94/NKG2	encounter	of	HLA-E	on	cell	activation
3.2.1	Methodology	(CD107a	surface	mobilization	assay)
To evaluate the capacity of CD94/NKG2A and CD94/NKG2C to regulate cell activation (de-
granulation) upon encounter of target cells, CD107a surface mobilization assay was performed. 
Three-color flow cytometriy analysis with specific antibodies against CD107a, NKG2-A or 
-C, and NKp46 or CD3 allows to electronically gate on T and NK cells expressing NKG2-A+ 
or -C+ and subsequently analyze these cells for CD107a expression (Fig. 3.11 A). The amount 
of CD107a+ NKG2-A and -C double negative NK or T cells was calculated by subtracting 
NKG2A+ CD107a+ and NKG2C+ CD107a+ from total CD107a+. Freshly isolated PBMC con-
tained a very low number of NKG2-A+ -C+ (referred to as double positive) cells which was 
found to be ≤ 0.5% of total PBL. Therefore, their double-representation within NKG2A+ and 
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NKG2C+ cells was ignored. This simplification was not applicable for NK cells when PBMC 
were co-cultured with 221 cells for 13 days prior to the CD107a surface mobilization assay be-
cause the amount of double positive cells sometimes even outnumbered NKG2C single positive 
cells after cell expansion. To overcome this problem, we negatively selected NK cells by mag-
netic-activated cell sorting (MACS) before incubation with target cells. The obtained high NK 
cell purity (> 98%) allowed then to analyze NKG2A+, NKG2C+, double negative and double 
positive NK cells without preceding electronic gating on NKp46+ cells (Fig. 3.11 B). For this 
purpose, cells were triple-stained with antibodies recognizing CD107a, NKG2A or NKG2C. 
Degranulation-associated CD107a surface expression was investigated upon incubation with 
the prototypic NK target cells, the MHC class I deficient K562 cells (Britten, et al., 2002), as 
well as 221-wt and 221-AEH cells.
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Figure	3.11	Gating	strategy	for	CD107a	surface	mobilization	assay
A, PBMC triple-stained with specific antibodies for CD107a-FITC, NKG2A-PE and NKp46-APC are 
gated on NKp46+ NKG2A+ cells (red) and subsequently analyzed for CD107a expression. To examine 
NKG2C+ NK cells, NKG2C-PE is used instead of NKG2A-PE. The same strategy is employed for T 
cells by the use of CD3-APC instead of NKp46-APC. B, To be able to gate on NKG2-A and -C co-
expressing NK cells,  negative selection by MACS is used which gives high-purity NK cells (left plot). 
After incubation with target cells, triple-staining with NKG2A-PE, NKG2C-APC and CD107a-FITC 
antibodies allows to gate on NKG2-A and -C double negative (R1), NKG2A+ (R2), NKG2-A+ and -C+ 
(R3) and NKG2C+ (R4) NK cells. These gates are used for the analysis of CD107a as indicated in (A).
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3.2.2	Reactivity	of	freshly	isolated	PBL	
NK cells from freshly isolated PBL, expressing NKG2-A or -C show about the same reactivity 
towards K562 and 221-wt cells when tested in the CD107a degranulation assay. When com-
pared to double negative NK cells, the NKG2 isoforms expressing Nk cells are the most reac-
tive cells against MHC class I deficient targets. Encounter of HLA-E on 221-AEH cells clearly 
inhibits the activity of NKG2A+ NK cells as compared to NKG2C+ cells, which display high 
reactivity with all three target cells (Fig. 3.12 A). 
Only a small fraction of T cells express CD94/NKG2 receptors and only this T cell fraction 
displays some CD107a on the surface. However, this is not found to be induced by target cell 
encounter since CD107a is found to a similar percentage on the surface of T cells incubated 
without targets (Fig. 3.12 B). Furthermore nodifference is found for NKG2A+ and NKG2C+ 
cells.
B       T cells    
A        NK cells
Figure	3.12	CD107a	surface	mobilization	assay	with	freshly	isolated	PBMC
Total PBMC were incubated alone or with 221-wt, 221-AEH or K562 target cells for 5 hours. 
Thereafter, NK (A) and T cell (B) subpopulations were analyzed as described in figure 3.11. 
Cells expressing both NKG2A and NKG2C account for 0.2% of PBL. Values for double 
negative cells were calculated as described in 3.2.1.  
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3.2.3	Reactivity	of	PBL	after	co-culture	with	221	cells
The expansion of NKG2C+ cells upon long-term culture with HLA-E expressing target cells 
raises the question if these expanded cells would show altered reactivity against HLA-E cells. 
In this context, it is important to mention that 721.221 cells used for co-culture are lethally ir-
radiated and are killed and/or disintegrated so that they are not detectable anymore by day 5. 
After 13 days of 221-AEH co-culture, the fraction of Nk cells inducible with any of the target 
cells investigated is reduced ba about 10% when compared to 221-wt co-cultured cells suggest-
ing expanded cells have rather diminished activation potential. However, it was striking that 
after co-culture with 221-AEH as well as 221-wt the NKG2C+ cells killed the HLA-e express-
ing 221-AEH cells significantly better than 221-wt cells suggesting that in this situation, HLA-
E functions as triggering ligand. Surprisingly, in contrast to freshly isolated cells, co-cultured 
NKG2A+ NK cells were hardly inhibited upon HLA-E encounter. The population of NK cells 
expressing both NKG2-A and -C showed an intermediate reactivity towards 221-AEH cells 
(Fig. 3.13). Taken, together, the results indicate that the progeny of cells induced to proliferate 
in the context of HLA-E does not differ from the cells cultured with 221-wt cells concerning 
their differential reactivity towards HLA-e target cells which is likely mediated via the CD94/
NKG2 receptors. 
We have further analyzed the CD94/NKG2 receptor expressing T cells, which werer largely 
CD56+ and were amplified upon 221-AEH co-culture. These cells show similar strong activity 
when incubated with any of the target cells. Despite of a minor difference in reactivity against 
HLA-E negative targets, the NKG2 receptor isoform did not characterize functionally distinct 
subsets. As found for freshly isolated T cells, only the CD94/NKG2 receptor expressing popu-
lation significantly expressed CD107a and again a sustantial portion displayed degranulation 
without addition of any target cell. Yet, long-term cultured cells show, unlike freshly isolated T 
cells, strong inducibility with NK target cells comparable to NK cells (Fig. 3.14).
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NK cells from 221-wt co-culture
NK cells from 221-AEH co-culture
Figure	3.13	NK	cell	analysis	of	a	CD107a	surface	mobilization	assay	after	13	days	of	
PBMC	co-culture	with	221	cells
PBMC co-cultured for 13 days with 221-wt (upper graph) or 221-AEH (lower graph) were 
MACS sorted for NK cells. Isolated NK cells were incubated with target cells and analyzed 
as described in figure 3.11.
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3.3.	Responses	to	HCMV	infected	cells
Human cytomegalovirus (HCMV) infection is known to downregulate classical MHC class I 
whereas HLA-E expression on the surface of infected cells stays constant or is upregulated by 
specific immune evasion mechanisms (Tomasec, et al, 2000). Immune cells recognizing HLA-
E via CD94/NKG2 receptors may therefore play a role in the immune reaction against HCMV. 
To investigate this possibility, we have studied co-culture of PBMC with embryonic lung fibro-
blasts (MRC-5 cells) infected with the AD169 HCMV lab strain.
3.3.1	Confirmation	of	HCMV	infection	and	function
MRC-5 cells infected with AD169 show a multiplicity of infection (MOI) dependent cytopatho-
genic effect (Fig. 3.15 A). 18 hours post infection, fibroblasts become round, small but still ad-
herent cells. This phenotype is reversible, lasts for two to three days until the typical fibroblast 
appearance is regained. 
An indication for the functionality of HCMV in the in vitro system is the exertion of virus-spe-
cific modulation of cellular protein expression. The well-known downregulation of MHC class 
I genes (Hengel, et al., 1996) was used to confirm infectin 72 hours after HCMV addition (Fig. 
3.15 B). At the same time, expression of CMV encoded FcR homologues was indirectly shown 
by increased binding of fluorescent labeled human IgG-Fc protein to infected cells as initially 
reported in 1976 by Keller et al. (Fig. 3.15 C).
Figure	 3.14	T	 cell	 analysis	 of	 a	CD107a	 surface	mobilization	 assay	 after	 13	 days	 of	
PBMC	co-culture	with	221	cells
Total PBMC were incubated with target cells and T cells were analyzed for CD107a surface 
expression as described in figure 3.11.
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3.3.2	Differential	responses	of	PBL	upon	exposure	to	HCMV	infected	fibroblasts
Co-culture experiments using PBMC of six different normal PBMC donors was performed in-
cluding both CMV+ and CMV- individuals as tested by PCR and the presence of CMV specific 
antibodies in the serum. Aside of a generally reduced cell growth or survival upon exposure to 
CMV-infected cells, PBL from three donors (two of which CMV- and one CMV+) showed no 
significant change in NK- and T cell composition as well as expression of any other surface pro-
tein tested. For one of the two CMV- donors, an expansion of NK cells was detected (Fig.	3.16). 
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Figure	3.15	Conformation	of	CMV	(Ad169)	infection	of	MRC-5	cells	
A, MRC-5 cells 18 hours post infection. B, C, Flow cytometry of MRC-5 cells 72 post 
infection. B, staining with a primary anti-MHC class I (W6/32) antibody detected with anti-
IgG-FITC. C, cells were incubated with recombinant human IgG-Fc-FITC.
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Concerning CD56 expression, these NK cells were CD56bright and many also CD16 positive. In 
line with the described preferential NKG2A+ phenotype of CD56bright cells, 93.5% of these Nk 
cells expressed NKG2A. 21.5% expressed further NKG2C, indicating that a substantial portion 
of these the cells expressed both NKG2 receptors (Fig. 3.16 A & B). The NK cell expansion 
was found to be dependent on the MOI and was accompanied by a drop in T cells numbers. 
This is opposite of what is found when PBMC are cultured alone or with uninfected fibroblasts. 
In this case, NK cell numbers drop rapidly and T cells expand or survive preferentially (Fig. 
3.16 C, left panels). Although the numbers of NK cells droped again after the expansion phase, 
at day 14 of co-culture with CMV infected fibroblasts, close to 80% of the lymphocytes of this 
donore were NK cells. On the other hand, T cells, which comprised 65% of freshly isolated 
lymphocytes were in this case found to be less than 20% after exposure to CMV (Fig. 3.16 C, 
right panels). 
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Figure	3.16	Expansion	of	NK-cells	upon	co-culture	of	PBMC	with	CMV	infected	fibro-
blasts
A, Flow cytometry of PBMC co-cultured with CMV (Ad169, MOI 5) or mock infected 
MRC-5 cells at day 7, 12 and 14. B, Receptor expression of NK cells at day 12 of co-culture. 
Gate used for analysis is indicated in (A). C, Cell numbers (left) of NK and T cells at various 
time points as well as their contribution to total PBL (right). Representative for two experi-
ments of one CMV negative PBMC donor (number 5 in table 3.1).
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For two donors (one CMV+ by PCR, one CMV-) a T cell response was obtained whereas other 
lymphocyte populations disappeared upon CMV exposure due to cell death. Infected fibroblasts 
(MOI 1) led to a larger proportion of T cells expressing CD56 (Fig. 3.17). In this case, a MOI 
dependency was not found as incubation with superinfected fibroblasts led to rapid cell death 
of T cells as well. Increased frequency of CD56+ T cells could be due to upregulation of CD56 
expression or expansion of a small subset of T cells already expressing CD56. The remaining 
T cells were long-lived, being still viable until day 15 to 17 of co-culture, outlasting cells co-
cultured with mock infected fibroblasts. NKG2A expression increased within both CD56- and 
CD56+  T cells until day 10 or day 12, respectively, followed by a subsequent decrease (Fig. 
3.18). In contrast, NKG2C was hardly detectable on CD56- T cells throughout the co-culture 
but was expressed by CD56+ T cells. After a slight drop of NKG2C expressing cells until day 
12, the decreased NKG2A expression at day 15 goes along with a relative increase of NKG2C 
expression on CD56+ T cells. Interestingly, the cell surface level of CD56 on NKG2C+ T cells 
was comparable to CD56bright NK cells.
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Figure	3.17	Increased	expression	of	CD56+	on	T	cells	upon	co-cultore	with	CMV	in-
fected	fibroblasts
PBMC were co-cultured with CMV (Ad169, MOI 1) infected or mock infected MRC-5 cells 
and their surface protein expression was analyzed at day 7, 10, 12 and 15. Shown is an ex-
periment with PBMC from donor 1 of table 3.1, representative of four performed with cells 
from two different donors.
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3.3.3	Preparation	of	a	CMV	(TB40)	virus	stock
The response of PBMC to virus infected cells may depend on both the virus strain and the cell 
type used for infection and co-culture. Ad169, the HCMV lab-strain used for all co-culture 
experiments, is not capable of infecting endothelial cells, a cell type infected by HCMV in 
vivo (Grefte, et al., 1993) and therefore of interest for the use in an in vitro co-culture system. 
Another HCMV lab-strain, called TB40, still carries the capability to infect endothelial cells 
such as Human Umbilical Vein Endothelial Cells (HUVEC). To prepare a TB40 stock for co-
culture experiments, the virus was amplified in MRC-5 cells, purified using a sorbitol gradient, 
centrifuged, resuspended in PBS, aliquoted and titrated (see chapter 2.2 for more information). 
In total, 3 ml TB40 suspension with a titer of 5 x 107 plaque-forming units (PFU) per ml was 
obtained. 72 hours post infection of HUVEC with TB40, cells showed increased binding of 
human-IgG-FC and about two thirds of the cells downregulated MHC class I expression. The 
remaining one third upregulated MHC class I, probably representing cells where the HCMV 
life-cycle is not yet completed (Fig 3.19). Thus a TB40 stock for future studies in the context 
of endothelial CMV infection was successfully obtained and will allow the investigation of the 
interaction of NK and T cells with CMV infected endothelial cells.
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Figure	3.18	NKG2-A	and	-C	expression	on	T	cells	upon	PBMC	co-culture	with	CMV	
infected	fibroblasts
Analysis of PBMC co-cultured with CMV (Ad169, MOI 1) infected MRC-5 for the expres-
sion of NKG2A and NKG2C. Cells were triple-stained with anti-CD56-FITC, anit-CD3-
APC and anti-NKG2A-PE or anti-NKG2C-PE. An exemplary dot-blot shows the regions 
used to gate on CD56+ (R1) and CD56- (R2) T cells. Shown is an experiment representative 
for two performed with donor number 1 of table 3.1. 
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Figure	3.19	Confirmation	of	HUVEC	infection	by	CMV	(TB40)
Flow cytometry of HUVEC 72 hours post infection. Cells were incubated with a primary 
anti-MHC class I (W6/32) antibody and with anti-IgG-FITC for detection (left histogram) 
or with recombinant human IgG-Fc-FITC (left histogram). The fraction of HUVEC that up-
regulated MHC class I surface expression could represent yet uninfected cells which have 
encountered CMV.  
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4.	Discussion
In this work, we have investigated subpopulations of NK and T cells characterized by the ex-
pression of the CD94/NKG2 receptors and tested potential functional differences of these popu-
lations. This is of relevance since it became apparent over the last decade that certain subsets of 
peripheral blood lymphocytes, previously thought to constitute homogenous populations with 
rather common functions, have to be further subdivided to reflect the actual situation.
For example, expression of the Ig-superfamily member CD56 (N-CAM) was identified to be a 
useful surface marker on NK cells and a subset of T cells, although its function on these cells 
remains elusive as neither homophilic binding (as reported for neuronal cells) nor an impact on 
cytotoxicity was detected (Lanier, et al., 1991). Especially concerning natural killer cells, the 
expression pattern of CD56 was useful to distinguish between primarily cytotoxic cells being 
CD56dim and mainly cytokine producing CD56bright cells. The functional difference is indicated 
on the one hand by differential expression of CD16, a low affinity receptor for IgG mediating 
ADCC and on the other hand by L-selectin (CD62L) which is a homing marker for periph-
eral lymph nodes (figure 3.2). In human peripheral blood, the predominant NK cell subset, 
representing 90% of NK cells, are CD56dim CD16+ CD62Llow/- and the remainder is CD56bright 
CD16low/- CD62L+. Conventionally, natural killer cells are identified in flow cytometry as CD3- 
CD56+ or NKp46+ cells. A small population of NKp46+ CD56- NK cells is excluded if CD3- 
CD56+ is used for identification, however these cells seem to have a dysfunctional phenotype, 
e.g. when analyzed in viremic HIV patients where they are expanded (Mavilio, et al., 2005). 
This indicates the importance of CD56 expression for the appropriate functioning of NK cells.
Furthermore, CD56 is expressed on peripheral blood T cells, which comprise about 9% of the 
total CD3+ population and are enriched in CD8 positive cells (> 90%; Ohkawa, et al., 2001). 
Within the CD8+ population, CD56 expression was found to correlate with an effector pheno-
type (Pittet, et al., 2000). Cytokine-induced activation and potent anti-tumor functions similar 
to mouse NK1.1+ T cells, termed NK-T, led to the use of this term for human CD56+ T cells 
(Campbell, et al., 2001). However, it is important to distinguish NK-T from the CD1d restricted 
iNKT, which represent less than 1% of CD3+ CD56+ cells (Ohkawa, et al., 2001) and only a 
subset of iNKT expresses CD56 (Kim, et al., 2002). 
4.1	CD94/NKG2	receptor	expression	in	peripheral	blood
In this work, members of the so-called “natural killer cell receptors” (because initially and 
mainly found on NK cells), the heterodimeric CD94/NKG2 receptors were analyzed to in-
vestigate their potential to characterize additional functionally distinct subpopulations of NK 
and T cells. NKG2 receptor chains are only expressed on the cell surface when paired with the 
invariant CD94 chain and 5 different NKG2 variants have been described to be generated from 
3 distinct genes and by differential splicing. Of these the heterodimers of CD94/NKG2A or 
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CD94/NKG2C are the most prominently expressed forms, which makes theses two members 
the most promising candidates to exert important activities. Though both CD94/NKG2-A and 
-C recognize the same ligand, they transmit converse signals, raising the question if differential 
expression classifies functionally distinct PBL subsets. The expression of NKG2 receptors in 
non-activated PBL is to a large degree mutually exclusive, but a rare, consistently found popu-
lation expresses both NKG2A and NKG2C (Fig. 3.3). Considering the antagonistic signals, a 
mechanism to regulate NK cell activation by means of transient NKG2 receptor co-expression 
was proposed. Furthermore, NKG2A was found to be upregulated on NKG2C+ cells following 
treatment with IL-12 whereupon these cells are inhibited for cytotoxicity against LCL 721.221 
cells transfected with the corresponding ligand HLA-E (Sáez-Borderías, et al., 2009).
Analysis of NKG2-A and -C in CD56+ NK and T cell subpopulations revealed a preferential 
expression of both receptors on CD56bright NK as compared to CD56dim and an overrepresenta-
tion within the CD56+ T cell subset (Fig. 3.5). Because CD56bright NK and CD56+ T cells account 
for only 1.5% and 6% of PBL, whereas CD56dim NK and CD56- T cells represent about 15% 
and 64%, respectively, the majority of NKG2-A and/or -C expressing cells belong to the latter 
groups. In either case, the surface expression of the inhibitory NKG2A isoform clearly outnum-
bers all other CD94/NKG2 receptors as most of the cells that stain for the invariant CD94 chain 
also stain for NKG2A (Fig. 1.2 A). This argues for an overriding importance of NK and prob-
ably also T cell inhibition via CD94/NKG2A in healthy individuals. Furthermore, the expres-
sion of the inhibitory NKG2A on NK cells scarcely differed between individuals, whereas the 
activating NKG2C varied widely. Deletion of NKG2C within healthy individuals (Miyashita, 
et al., 2004) and joint transcriptional regulation of both isoforms in NK cells (I. Karas, Ph.D. 
thesis, 2009), provides evidence for a similar function of the activating isoforms. Aside of that, 
co-expression of NKG2C and NKG2E may occur and cooperation would likely promote NK 
cell activation upon HLA-E encounter. However, the lack of a specific antibody for NKG2E did 
not allow to investigate this assumption.
In regards of  the diverse group of killer immunoglobin-like receptors (KIR) which recognize 
various MHC class I molecules and comprise, similar to CD94/NKG2 proteins, inhibitory and 
activating members, these are, similar to the NKG2 receptors, mainly found on NK cells but 
also present on a small population of T cells. Usage of connatural or identical signaling motifs 
(mainly ITIMs and ITAMs) and recognition of “self” via MHC class I by both, the NKG2 and 
KIR receptor families, opens the possibility for partially overlapping functions.  More than 50% 
of KIR expressing T cells are found to express in addition a CD94/NKG2 member (Fig. 3.6). 
Since on average, only about 2% of T cells express KIR and 6% express NKG2 receptors this 
indicates the existence of a specialized subset of T cells capable to express NKG2, KIR or both 
receptors. CD1d restricted iNKT cells are known to express various NCR but as they make up 
only 0.1% of PBL (Lee, et al., 2002), also canonical T cells, expressing a variable TCR, should 
therefore contain further specialized subpopulations characterized by NK receptors. They likely 
belong to the so-called NKT-like cells, usually classified by the expression of another NK re-
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ceptor, CD161 (NKRP1), which exhibits a broad spectrum of functions (Godfrey, et al., 2004). 
4.2	Expansion	of	PBL	subpopulations	upon	221	cell	co-culture
Recognition of a specific ligand by a cell surface receptor could lead to changes in receptor 
expression as well as result in functional activation and/or proliferation of the cells. Some 
evidence has been reported that this may be the case for the encounter of HLA-E by CD94/
NKG2C, as co-culture of PBMC with cells expressing HLA-E led to proliferation of NKG2C+ 
cells (Guma, et al., 2005). We have therefore tested this in long-term in vitro culture of lympho-
cytes which can be supported by the addition of irradiated lymphoid cell lines (LCL) as feeder 
cells (Hardy, et al., 1970). To avoid allogeneic responses, we used the MHC-class Ia deficient 
LCL 721.221 (221-wt) cell line. This mutant of the B cell lymphoblastoid cell line LCL.721 
(Shimizu, et al., 1988), which was generated by γ-ray mutagenesis, expresses intracellular but 
not cell-surface HLA-E because MHC-class I derived peptides are needed for surface expres-
sion of HLA-E and these cells lack classical MHC class I (Lee, et al., 1998). To investigate the 
influence of HLA-E, the ligand for NKG2A and -C, LCL 721.221 cells transfected with an ex-
pression construct for  HLA-E, termed 221-AEH, were used. The HLA-E expression construct 
contains a hybrid HLA-E gene in which the HLA-E leader peptide sequence was substituted 
for the HLA-A2 signal peptide sequence. The HLA-A2 signal peptide generated loads into the 
HLA-E peptide binding site and leads to cell-surface expression of bona-fide HLA-E by 221-
AEH cells (Lee, et al., 1998). 
In the established assay, PBMC were co-cultured with 221-wt or 221-AEH cells and cell num-
bers as well as surface receptor expression was monitored over a period of two weeks. At a first 
glance, an obvious difference in the time frame of cell expansion was observed in dependence 
of the cells added to the PBMC. PBMC cultured with 221-wt cells showed a peak of cell expan-
sion at day 7 and those cultured with 221-AEH cells at day 13 whereas culture without 221 cells 
led to no real expansion during the whole period (Fig. 3.8). Within the lymphocytic fraction, T 
cells accounted for the cell expansion upon 221-wt co-culture. This expansion of T cells was 
found to a significantly lesser degree in 221-AEH co-cultures (Fig. 3.9 A). The observed T cell 
expansion is likely driven by a cytokine/chemokine milieu produced and cell-cell contacts pro-
vided by the irradiated feeder cells. It remains however unclear why 221-wt cells have stronger 
effects in this respect when compared to 221-AEH cells. In contrast to T cells, NK cells started 
to proliferate only after day 7 of either co-culture and displayed, in dependence of certain 
donors, a more strongly pronounced amplification upon 221-AEH co-culture peaking at days 
11-13 (Fig. 3.9 B). The expanding cells had the appearance and the surface markers of large 
granular lymphocytes and seemed rather short-lived as a rapid drop in cell numbers occurred 
following cell expansion. Interestingly, presence of HLA-E on the cells in the co-culture system 
led to a preferential outgrowth of NK and T cells expressing the activating CD94/NKG2C re-
ceptor (Fig. 3.10 A). It seems that triggering of the activating CD94/NKG2C receptor by HLA-
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E can either upregulate NKG2C expression and/or  give a preferential growth signal to NKG2C 
expressing cells. However, since cells expressing NKG2A also amplified, although usually not 
to the same extent, the events in the culture are more complex. It could be that NKG2C cells 
stimulated by HLA-E would secrete growth factors providing a stimulus also to the NKG2A ex-
pressing cells or NKG2A expression on immature cells in the mixture can be directly triggered 
by HLA-E or other growth promoting molecules of the feeder cells. Another effect mediated 
preferentially by the 221-AEH cells, the appearance of CD56+ T cells with NKG2C expres-
sion was not found for all PBMC donors. Importantly, NKG2C in the amplified cultures was 
expressed by both NK and T cells, when the latter were also amplified. NKG2C expression 
was mostly on CD56+ T cells (Fig. 3.10 B & C). In contrast, NKG2A+ cells were expressed 
almost exclusively on NK cells. In this regard, it is important to note that NKG2A positive cells 
outnumber NKG2C cells by far when freshly isolated T cells are analyzed, i.e. when the final 
culture contained comparable amounts of NKG2A and NKG2C cells, the NKG2C cells had 
much more proliferated. Alternatively, we can not exclude that NKG2C expression was also 
upregulated on NK cells not expressing this receptor at the beginning of the culture.
It has been described for murine T cells expressing low levels of CD94 that they bind to tetra-
mers of the HLA-E homologue Qa1 supported by CD8 whereas NK cells bound the tetramers 
only if high levels of CD94/NKG2 receptors were expressed (Gunturi, et al., 2003). If this is 
also true for humans, CD8 could be involved during the initiation of NKG2C+ T cell expansion.
CD94/NKG2A expression was shown to be a clonal feature of a restricted subset of CD8+ T 
cells, the main NCR expressing T cells, where TCR specificity is involved in the control of 
CD94/NKG2A expression and committed cells express cell-surface NKG2A following recent 
antigen encounter via TCR (Jabri, et al., 2002; Braud, et al., 2003). The MHC class-Ia defi-
ciency of 221 cells may therefore explain that almost no NKG2A+ T cells are generated upon 
co-culture as TCR stimulation via MHC class Ia can not occur. 221-AEH cells are modified to 
express the HLA-E*0101 allele, one of two variants frequently found in humans, and provide 
HLA-A2 signal peptides for loading into HLA-E. Considering that TCR specificity may also 
play an important role, donor dependency of the NKG2C+ T cell response could be explained 
by absence or presence of allo-reactive TCR to the HLA-E allele and also the bound peptide can 
either be recognized as “self” (HLA-A2+ donor) or “non-self” (HLA-A2- donor). 
NKG2C mRNA is present in many CD8+ T cells but CD94/NKG2C surface expression was 
reported to occur late in T cell development exclusively by highly differentiated effector cells 
(Arlettaz, et al., 2004). When murine cells were cultured in vitro, apoptosis was inversely re-
lated to the expression of CD94 on CD8+ T and NK cells (Gunturi, et al., 2003), which could 
provide one explanation for the increased appearance of CD94+ NKG2C+ cells upon long-term 
co-culture. As NKG2C functions as a co-stimulatory receptor on T cells, it could play an impor-
tant role during the final steps of an immune response. When the obtained TCR stimulation is 
insufficient due to low concentrations of the specific antigen, NKG2C might add to the activa-
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tion. Similarly, the expansion of cells expressing NKG2C upon 221-AEH co-culture could be 
preferentially induced by the additional activating signal transmitted via NKG2C. Though NK-
G2A and NKG2C mRNA is present in some T cell clones, surface expression has been reported 
to be mutually exclusive (Arlettaz, et al., 2004). However, in this work we observed that about 
1% T cells express NKG2A and NKG2C after 221-AEH co-culture (Fig. 3.14).	These cells can 
be expected to be very rare among freshly isolated PBL and may amplify during co-culture.
HLA-E specific invariant CD8+ T cells have been reported upon Salmonella enterica (Salerno-
Goncalves et al., 2004) and M. tuberculosis (Heinzel, et al., 2002) infection and their preva-
lence in peripheral blood was recently reported (Aziz, et al., 2009).	Furthermore, increasing 
evidence suggests that bacterial peptides, presented by HLA-E may lead to binding of corre-
sponding TCRs (Heinzel, et al., 2002; Salerno-Goncalves, et al., 2004). However, as 221-AEH 
cells express HLA-E and an HLA-A derived peptide which should load into the HLA-E, it is 
more likely that T cells amplify in the co-culture due to NKG2C functioning as a co-receptor 
for T cell activation and not due to HLA-E recognition by TCR. The cell-surface level of HLA-
E on 221-AEH cells is much higher as compared to 221 cells which can be induced to express 
HLA-E by the addition of peptides (Salerno-Goncalves, et al., 2004). This could promote the 
lower-affinity interaction of NKG2C and HLA-E, thereby inducing preferential NKG2C+ cell 
expansion. NKG2C expression on T cells might be important to provide co-activation for ex-
ample in the case of viral infections, as viruses can upregulate HLA-E surface expression (To-
masec, et al., 2000; Megret, et al., 2007).
Similarly, the (in comparison to T cells less pronounced) overrepresentation of NKG2C+ NK 
cells when exposed to HLA-E expressing 221 cells could reflect a response mechanisms to ab-
normally high HLA-E surface expression. 
Taking to account that most NK cell receptors were found to require co-stimulation of more than 
one activating receptor in order to induce activation (Bryceson, et al., 2006), CD94/NKG2C 
encounter of HLA-E could provide one of the important signals needed to activate NK cells, in 
addition signals from e.g. members of the leukocyte Ig-like receptors (LILR), which can bind 
conserved regions of MHC class I molecules might contribute.
4.3		Activation	of	CD94/NKG2	receptor-expressing	cells
At first glance, the existence of inhibitory and activating receptors for the same specific ligand, 
sometimes even co-expressed on the surface of a single cell, is somewhat puzzling and might 
reflect tightly controlled regulatory mechanisms. Aside of CD94/NKG2-A and -C, this prin-
ciple is also observed for killer-cell immunoglobulin-like receptors (KIR). For example, the 
inhibitory KIR2DL1 and activating KIR2DS1, both recognizing HLA-C, constitute oppositely 
signaling receptors recognizing the same ligand (Stewart, et al., 2005). Affinity differences of 
the receptor-ligand binding can favor the functional impact of the higher-affinity member. For 
receptors recognizing constitutively expressed “self” ligands like MHC class I molecules, the 
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inhibitory receptor form would essentially have to show higher affinity as compared to its ac-
tivating counterpart to render such a mechanism possible without causing autoreactivity. The 
remarkable finding for KIR2DL1 and KIR2DS1 as well as CD94/NKG2A and CD94/NKG2C 
is, that this prerequisite is fulfilled. It points at its functional importance to control cell activa-
tion. On the other hand, CD94/NKG2E, another activating HLA-E specific receptor, was shown 
to have indistinguishable ligand binding affinities from CD94/NKG2A (Kaiser, et al., 2005). 
Unfortunately, to date no NKG2E specific antibody exists and the consequence of this can not 
be further analyzed. Because co-transcription of various NKG2 family members does not cor-
relate with cell-surface protein co-expression (Arlettaz, et al., 2004), it would first be necessary 
to clarify wether NKG2E translation and surface mobilization takes place. Regulation of the 
sensitivity of cells towards activation via relative surface-levels of activating and inhibitory 
receptors for the same ligand would also be conceivable. The recently published IL-12 depen-
dent upregulation of NKG2A expression on NKG2C+ NK cells (Sáez-Borderías, et al., 2009) 
substantiates this possibility.
To address the impact of NKG2 receptor expression before and after co-culture on NK and T 
cell activation, CD107a surface expression was analyzed after incubation with MHC class I 
deficient target cell lines (221-wt and K562) and the HLA-E expressing 221-AEH cell line. 
CD107a (LAMP-1) is found ubiquitously on the luminal side of lysosomal and endosomal 
membranes and reaches the cell surface upon vessicle-membrane fusion and effector-molecule 
release. CD107a surface expression therefore correlates with cytokine secretion and cytotoxic-
ity mediated by NK as well as CD8+ T cells (Betts, et al., 2003; Alter, et al., 2004). Analyzing 
CD107a surface expression by flow cytometry is a possibility to assess the ability of these 
cells to degranulate, which serves as an indication for cell activity. Reflecting the eponymous 
property of NK cells to spontaneously kill MHC class I deficient targets, incubation of freshly 
isolated PBMC with 221-wt and K562 cells leads to activation of NKG2-A and/or -C express-
ing and non-expressing NK cells (Fig. 3.12 A). If 221-AEH cells were used as targets, NKG2A+ 
NK cell activation was inhibited to a large extent, emphasizing the functional consequence of 
CD94/NKG2A receptor interaction with HLA-E. It has to be pointed out that this is an HLA-E 
dependent inhibition under otherwise activating conditions (HLA class Ia deficient target cells), 
indicating that HLA-E binding to NKG2A is a bona fide inhibitory “self” signal to NKG2A+ 
NK cells. Unexpectedly, NKG2C+ NK showed equal activity upon incubation with 221-wt or 
221-AEH cells. This indicates an insufficient contribution of NKG2C to induce degranulation 
of NK cells activated due to missing classical MHC class I expression by the target cells.
In the case of T cells, NKG2-A and/or -C expressing cells make up only a very small fraction. 
CD107a surface expression was not increased by target cell incubation but around 6% of T cells 
expressing either NKG2 receptor displayed surface CD107a without encounter of target cells, 
which is in contrast to T cells not expressing NKG2 (Fig. 3.12 B). This spontaneous degranula-
tion without target cells probably indicates an increased activity of NKG2 receptor expressing 
71
T cells. 
The next aspect to analyze was if long-term co-culture of PBMC with 221-wt or 221-AEH cells 
alters the reactivity towards target cells. Increased numbers of NKG2-A and -C co-expressing 
NK cells in the amplified population allowed to include this population in addition to cells ex-
pressing only NKG2A or NKG2C. The NK cells from co-culture with 221-wt and 221-AEH 
cells displayed largely similar differences in degranulation activity between the subpopulations 
defined by NKG2 receptor expression. This indicates that cells which specifically expand upon 
encounter of HLA-E do not change their functional properties in comparison to cells which do 
not expand to the same degree but are kept in co-culture with the feeder 221-wt cells. It turned 
out that one major difference compared to freshly isolated cells exists:  NKG2C+ NK represent 
the least activated population if MHC class I deficient target cells are used but get highly acti-
vated upon encounter of HLA-E suggesting that HLA-E can function as activating ligand for 
NKG2C+ cells from the co-cultures. In parallel, the inhibitory effect of NKG2A interaction with 
HLA-E is reduced. It is conceivable that in vivo, upon infection with pathogens that may lead to 
upregulation of HLA-E surface expression by loading of viral peptides into HLA-E, increased 
numbers of NK cells expressing NKG2C and reactive with e.g. HLA-E/viral peptides would 
be beneficial and this could be further supported when at the same time the inhibitory effect of 
NKG2A after binding to HLA-E is less pronounced. 
It has to be mentioned that NKG2A and NKG2C double-negative NK cells appeared to be more 
activated by 221-AEH cells than by 221-wt, suggesting a significant contribution of other re-
ceptors recognizing HLA-E. Potential candidates would be activating LILR and CD94/NKG2E 
or H.
The six fold higher affinity of CD94/NKG2A interaction with HLA-E as compared to CD94/
NKG2C adumbrates that inhibitory signaling should dominate in NKG2-A and -C double posi-
tive cells. Surprisingly, the double-positive cells display intermediate activity and hardly any 
difference between 221-wt and 221-AEH target cell induced degranulation. It therefore appears 
that the very fast association and dissociation constant of the interaction between CD94/NKG2 
and HLA-E (Vales-Gomez, et al., 1999) could probably make the affinity difference less rel-
evant.
The expanding T cells expressing NKG2-A and/or -C upon 221-AEH co-culture, which are 
mainly CD56+, display high levels of spontaneous CD107a surface expression without target-
cell contact, similar to freshly isolated T cells. Hoever, T cells amplified after co-culture and 
expressing any of the two analyzed CD94/NKG2 isoforms can be induced to degranulate by 
MHC class I deficient target cells and this inducibility is a property largely restricted to NKG2-
A and/or -C expressing T cells (Fig. 3.14).
Notwithstanding HLA-E seemed to induce the amplification of these cells, the response against 
221-AEH cells does not significantly differ from other target cells. This again stresses the im-
portance of additional activating interactions between the T cells and target cells. The small 
fraction of NKG2-A and - C negative T cell, activated upon 221-AEH cell co-culture, could be 
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comprised of cells recognizing HLA-E via TCR although further investigation is necessary to 
substantiate this assertion. Collectively, these results provide evidence that expression of CD94/
NKG2 receptors by T cells can be used as a cell-surface marker to identify cells capable of TCR 
independent recognition of target cells.
Considering that HLA-E does not influence the inducibility, it is reasonable to hypothesize that 
additional ligands/receptors exist and account for the high reactivity of these cells. It is possible 
that the major function exerted by CD94/NKG2 receptors on T cells could be to facilitate the 
attachment to target cells more than a contribution to cell activation as degranulation is found 
largely independent of the CD94/NKG2 isoform.
4.4	PBL	co-culture	with	HCMV	infected	fibroblasts
The importance of NK cells and cytotoxic T lymphocytes in viral defense has been clearly 
shown by a multitude of studies (Andoniou, et al., 2006; Wiesel, et al., 2009). Human cyto-
megalovirus (HCMV) uses various strategies to evade host immune reactions enabling the virus 
to establish latent infection. Amongst them are mechanisms that specifically target MHC class 
I expression, including downregulation of classical MHC class Ia whilst keeping or increasing 
HLA-E expression (Tomasec, et al., 2000). Guma et al. (2004) provided evidence that CMV can 
shape the NK and T cell receptor repertoire in healthy carrier individuals, resulting in increased 
frequencies of NKG2C+ cells. Furthermore, NKG2C+ NK cells were found to be specifically 
amplified upon co-culture of PBMC with CMV infected embryonic lung fibroblasts (MRC-5 
cells) (Guma, et al., 2006). Absence of the viral gene region US2-11, responsible for MHC 
class Ia downregulation, impaired the response whereas MHC class I homologues and HLA-E 
upregulating UL40 did not have an effect. MRC-5 cells reportedly do not express cell-surface 
HLA-E (Tomasec, et al., 2000; Guma, et al., 2006), suggesting either an indirect effect leading 
to NKG2C+ NK cell amplification or the existence of a yet undefined ligand of host or viral 
origin active as amplification stimulus. As described above, co-culture of PBMC with 221 cells 
provided evidence, that both CD56+ T and NK cells are similarly induced to proliferate upon 
ligand-binding of CD94/NKG2 receptors during long-term co-culture. To assess if encounter of 
HCMV infected cells can alter the prevalence of PBL subpopulations in a similar way, PBMC 
were co-cultured with CMV infected fibroblasts for up to 14 days in the presence of 10 interna-
tional units recombinant human IL-2, supplemented from day 3 on. 
Similar to what was found for 221 co-culture, the response of CD56+ PBL subpopulations 
was to a large degree dependent on the blood donor. In the limited number of samples stud-
ied, HCMV seroprevalence was not indicative for a certain response and further investigation 
would be necessary to clarify whether latent HCMV infection of a donor would hamper or sup-
port amplification of certain cell subpopulations in vitro. 
For one out of six PBMC donors, strong, HCMV induced proliferation of natural killer cells 
was found (Fig. 3.16). The amplified NK cells were CD56bright, a subset known to be increased 
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at sites of inflammation (Strowig, et al., 2008). The vast majority (93.5%) expressed NKG2A 
and a high percentage co-expressed NKG2C (15%, data not shown). Expression of CD16 in-
dicates the potential to perform ADCC and common HLA-DR expression is suggestive of an 
activated phenotype (Lima, et al., 2001). Taken together, cell surface protein expression of NK 
cells specifically amplified upon co-culture with HCMV infected cells adumbrates a potential 
to counteract the virus. In another two PBMC donors, elevated frequencies of CD56+ T cells 
were found (Fig. 3.17) if MRC-5 cells were infected with an MOI not higher than 1 as PBMC 
did not withstand co-culture with cells carrying a higher viral load. The appearance of these 
CD56+ T cells was not accompanied by strong total cell expansion. This could be due to: First, 
CD56 is found on a subpopulation of T cells which frequently co-express other “NK cell re-
ceptors” (NCR) like CD94/NKG2 and was previously even used as a marker for natural-killer 
T (NKT) cells. NCR+ T cells were implicated as major contributors to determine the outcome 
of viral infections (Golden-Mason, et al., 2007). It could be that expansion of this very small 
initial population could take place. Second, activation-induced upregulation of CD56 could 
have occurred, which has been shown for example upon CD3/TCR stimulation resulting in in-
creased numbers of CD56+ T cells whilst total cell numbers remain unchanged (Kelly-Rogers, 
et al., 2006). Third, CD56 expression on T cells might be indicative of senescence of the cells. 
For example CD56 expression has been implicated with longevity, senescence and exertion of 
TCR independent immune cascades previously (Lemster, et al., 2008) as well as generally with 
cytolytic effector functions of CD8+ CTL (Pittet, et al., 2000). 
Taken together, the observed increased expression of NKG2C, correlating with the phenotype 
of highly differentiated cytotoxic T lymphocytes (Arlettaz, et al., 2004), could be indicative 
of a preferential “survival” of potent CD3+ CD56+ NKG2C+ effector cells which might be 
preferentially induced in response to HCMV.  It has to be mentioned that although fibroblasts 
are highly sensitive to CMV infection, the relevance of PBMC interaction with fibroblasts for 
CMV immunosurveillance in vivo is not clear. It may be more likely that cells of the vascular 
system, which had been implicated as potential sites of HCMV latency, are involved and for 
that reason, this work also provided the basis to test human vascular endothelial cells (HU-
VEC) as HCMV carriers in an additional co-culture system. To achieve this, a HCMV lab 
strain more closely related to primary isolates, named TB40, has to be used for infection of 
HUVEC and corresponding virus stocks were prepared. This will allow to analyze the re-
sponse of PBMC to HCMV in a biologically more relevant in vitro system, superior to reflect 
the in vivo situation.
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